Abstract
Ribosome biogenesis occurs in the nucleolus, a biomolecular condensate whose material properties are thought to be important for function. However, the molecular basis of nucleolar dynamics and their relationship to ribosome assembly remain incompletely understood. We present a platform for high-throughput fluorescence recovery after photobleaching (HiT-FRAP) and use it to screen hundreds of genes for their impact on dynamics of the nucleolar scaffold nucleophosmin (NPM1). We find that NPM1 dynamics and nucleolar morphology are sensitive to ribosome assembly state: accumulation of early preribosomal intermediates slows NPM1 dynamics and compacts the condensate, while accumulation of abortive late precursors accelerates dynamics and disrupts condensate integrity. These opposing biophysical states correlate with the strength of NPM1-pre-ribosome interactions. Importantly, mutations in the NPM1 intrinsically disordered region that alter pre-ribosome binding directly tune nucleolar dynamics. These results establish that ribosomal precursor assembly state determines nucleolar material properties through the strength of scaffold-pre-ribosome interactions and introduce HiT-FRAP as a platform for interrogating condensate dynamics broadly.
Graphical Abstract
Sheu-Gruttadauria et al. show that the material properties of the nucleolus are shaped by the assembly state of ribosomal precursors, which tune nucleolar dynamics and morphology through their interactions with the nucleolar scaffolding protein NPM1.
Introduction
Biomolecular condensates are membraneless organelles that are broadly implicated in many cellular processes, including nearly every step in the life cycle of an RNA (Shin and Brangwynne, 2017, Banani et al., 2017, Lyon et al., 2021, Alberti and Hyman, 2021). Over the last decade, increasing evidence suggests that many condensates form through biological phase transitions, driven by multivalent interaction networks that form between nucleic acids and intrinsically disordered regions (IDRs) in proteins (Mittag and Pappu, 2022). These interaction networks imbue condensates with an array of dynamic biophysical properties, including exchange with the environment, internal mixing, viscosity, and surface tension, resulting in material properties that range from liquid to solid-like. It is thought that these biophysical properties influence the biological function of condensates, as pathological mutations that promote aggregation are associated with disease (Shin and Brangwynne, 2017, Alberti and Hyman, 2021). Emerging work has begun to uncover the molecular principles that underlie condensate dynamics in reconstituted phase separating systems (Wang et al., 2022, Alshareedah et al., 2021, Boeynaems, 2019, Wang, 2018). However, mechanistically connecting these features to condensate function in living systems is challenging.
One of the first identified and largest biomolecular condensates in the cell is the nucleolus, whose primary function is coordinating ribosome biogenesis, a process essential for cell viability, growth, and proliferation (Donati et al., 2012, Lempiäinen and Shore, 2009, Golomb et al., 2014). Decades of studies have provided detailed molecular insight into this process (Klinge and Woolford, 2019). In humans, ribosome biogenesis begins with transcription of the 47S pre-ribosomal RNA (rRNA) by RNA polymerase I (Pol I), which is processed together with the RNA Pol III-transcribed 5S rRNA to yield the small subunit (SSU) 18S and large subunit (LSU) 28S, 5.8S, and 5S rRNAs (Fig. S1A). This rRNA scaffold undergoes modification, processing, and folding, concomitant with recruitment of 80 ribosomal proteins, all orchestrated by over 200 assembly factors (Klinge and Woolford, 2019, Bohnsack and Bohnsack, 2019, Dörner et al., 2023–02–10). The SSU and LSU proceed through over a dozen discrete intermediates, many of which have been structurally characterized (Broeck and Klinge, 2023–07–07, Singh et al., 2021, Klinge and Woolford, 2019, A and S, 2024 Aug).
In contrast to this precise understanding of ribosome biogenesis, the molecular underpinnings of nucleolar form and how they relate to ribosome assembly are only beginning to be understood. On the mesoscale, the nucleolus is composed of three concentric layers enriched for factors involved in sequential steps of ribosome assembly: the fibrillar center (FC) where Pol I transcription occurs, the dense fibrillar component (DFC) where SSU assembly and rRNA processing factors localize, and the granular component (GC) that houses factors involved in maturation of the pre-SSU and assembly of the pre-LSU (Krüger et al., 2007, Lafontaine et al., 2021, Boisvert et al., 2007) (Fig. S1A). A key scaffolding protein of the GC is nucleophosmin (NPM1), a pentameric protein bearing acidic and basic intrinsically disordered regions that mediate multivalent interactions with ribosomal proteins, assembly factors, and rRNA, promoting phase separation into the GC (Ferrolino et al., 2018, Mitrea, 2016, Riback, 2020). NPM1 is one of the most abundant nucleolar proteins and one of the best studied phase-separating scaffolds in the nucleolus (Brangwynne et al., 2011, Ferrolino et al., 2018, Mitrea, 2016), making it an attractive model for understanding how condensate properties emerge from constituent interactions.
Nucleolar assembly through phase separation leads to several biophysical properties that have been proposed to facilitate ribosome biogenesis. Firstly, it is thought that the three nucleolar layers are immiscible subphases kept distinct by differences in their surface tensions and viscosities, spatially organizing ribosome biogenesis in an assembly line (Feric, 2016). The interfaces of these subphases may be important for molecular hand-off between stages of assembly (Yao, 2019, Shan et al., 2023). Moreover, in vitro and bioinformatic work suggests that the interaction valency of pre-ribosomes with nucleolar scaffolds decreases during maturation through folding and processing of the rRNA, binding of ribosomal proteins, and departure of assembly factors (Riback, 2020, LaPeruta, 2023, LaPeruta et al., 2022), promoting the thermodynamic release of mature subunits. Lastly, nucleolar material properties, often described as liquid-like, are thought to be essential for proper ribosome biogenesis (Brangwynne et al., 2011), as optogenetic clustering of nucleolar scaffolds leads to rigidification and perturbed rRNA processing (Zhu, 2019). Nucleolar morphology is also often disrupted in cancer, aging, and neurodegeneration (Corman et al., 2023).
These observations support a compelling hypothesis that the biophysical features of the nucleolus are intrinsically coupled with its function in ribosome assembly. Indeed, recent advances have connected the multilayered organization of the nucleolus to rRNA processing, demonstrating that its concentric nature is templated by rRNA and its hierarchical maturation (Quinodoz et al., 2025–07–02, Shan et al., 2023, Riback, 2023). Moreover, previous imaging-based screens have coupled nucleolar morphology to defects in ribosome biogenesis (Nicolas, 2016, Farley-Barnes, 2018, Ogawa, 2021, V et al., 2018 Oct, Matsumori et al., 2022 Mar 23). However, what determines the dynamic material properties of the nucleolus and how these are mechanistically tied to ribosome assembly remain far less understood. Current understanding of nucleolar dynamics comes from in vitro reconstitution of isolated nucleolar constituents, as the field currently lacks tools for systematically measuring condensate dynamics in living cells. As a result, the molecular basis for nucleolar dynamics remains incompletely defined, limiting our ability to connect the emergent biophysical features of condensates to their function.
Here, we introduce a platform to systematically measure dynamics of biomolecular condensates in live cells. The most readily measurable biophysical property of condensates in living systems is macromolecular diffusivity as assessed by fluorescence recovery after photobleaching, or FRAP (Taylor et al., 2019). FRAP is a robust and quantitative technique that is widely accessible on commercial microscopes. However, it is also a largely manual technique. To overcome this limitation, we developed a method for High-Throughput Fluorescence Recovery After Photobleaching, which we call HiT-FRAP. This strategy allows FRAP to be used in arrayed genetic screens, enabling discovery of factors that influence condensate dynamics.
We apply HiT-FRAP to screen hundreds of genes for their impact on the dynamics of NPM1, using it as a proxy for GC dynamics. When combined with analysis of nucleolar morphology, we identify distinct nucleolar phenotypes associated with stages in ribosome assembly and an unexpected connection to mRNA processing pathways. Across phenotypic clusters, changes in NPM1 dynamics are mirrored by changes in nucleolar morphology and partitioning of NPM1 into the nucleolus from the nucleoplasm, suggesting that these readouts together report on the material state of the condensate. Characterizing ribosome biogenesis within these states reveals that they correspond to changes in pre-ribosome composition within the nucleolus: accumulation of early intermediates decreases NPM1 dynamics while accumulation of abortive late LSU intermediates increases exchange. These trends correlate directly with NPM1 partitioning into the nucleolus and the strength of its interactions with ribosomal intermediates, which suggests that the interactions that drive phase separation also dictate condensate material properties. We further demonstrate that mutations in the NPM1 IDR that alter pre-ribosome binding strength directly tune both nucleolar partitioning and dynamics. Together, these results establish that the assembly state of ribosomal precursors determines the dynamic biophysical properties of the nucleolus, providing a direct mechanistic tie between ribosome biogenesis and nucleolar material properties.
Results
HiT-FRAP: A platform for performing scalable automated FRAP
To identify factors that guide macromolecular dynamics in biomolecular condensates, we developed a platform to perform scalable, fully automated FRAP experiments called HiT-FRAP (Fig. 1A). This pipeline uses data-adaptive imaging strategies to automatically identify and bleach fluorescently labeled organelles in living cells and acquire movies to measure fluorescence recovery (Fig. 1B), eliminating the need for manual designation of regions of interest to increase experimental throughput. We also developed an automated analysis pipeline that quantifies fluorescence recovery for all bleach points across all acquired positions, normalizing to non-bleached organelles. We fit recovery data to a simple exponential to prevent over-fitting and export parameters that describe dynamics (t1/2 and mobile fraction, which represent time to 50% recovery and percentage of mobile molecules, respectively).
Figure 1: HiT-FRAP: A platform for performing scalable, automated FRAP experiments.

(A) Schematic overview of HiT-FRAP pipeline. See also: Methods. (B) Example images show automated FRAP steps. Left, segmentation of fluorescently labeled nucleoli (blue masks, see methods) and bleach point determination (red points). Below, zoom of single nucleolus bleach and recovery time course. Right, normalized FRAP curves generated from a single field of view. Raw intensities shown as solid line, single-exponential curve fit shown as dotted line. (C) NPM1-mNeonGreen cell lines were treated with 10 mM sodium azide and 6 mM 2-deoxyglucose for 10 min to deplete cellular ATP prior to bleaching experiment. Left, images of single nucleolus bleach and recovery time course for vehicle and ATP deplete. Right, FRAP curves (n = 250 nucleoli, error bars are 95% CI). (D) NPM1-mNeonGreen cell lines were treated with 10 μM MG132 for 1 hr (left) or 200 μM sodium arsenite for 1 hr prior to bleaching experiment. (n = 250 nucleoli, error bars are 95% CI).
We applied HiT-FRAP to interrogate dynamics in the largest nucleolar subcompartment, the GC, using NPM1 as a readout. We chose HeLa cells as a model system because they lack functional p53, which is typically activated by nucleolar stress, allowing us to study disruptions in ribosome biogenesis without confounding cell death responses. To monitor NPM1 dynamics, we used CRISPR-based tagging of the endogenous NPM1 gene to generate cell lines with C-terminal fluorescent protein tags: a homozygous NPM1-mNeonGreen line and a heterozygous NPM1-mScarlet line, the latter of which maintains wild-type NPM1 expression levels (Fig. S1B). Both lines show similar NPM1 localization, exhibit FRAP recovery kinetics consistent with published values (Brangwynne et al., 2011), and have normal rRNA processing relative to unedited cells (Fig. S1C–D), validating their use as reporters of nucleolar dynamics.
To validate HiT-FRAP, we measured relative differences in NPM1 dynamics using perturbations previously reported to impact exchange by FRAP. Firstly, we rapidly depleted ATP with 2-deoxyglucose (2-DG) and sodium azide to block both glycolysis and oxidative phosphorylation, which had been previously shown to decrease NPM1 mobility (Feric, 2016). We found that NPM1 exhibited slower recovery (~1.5-fold) and a lower percentage of mobile molecules (~2-fold) as compared to vehicle alone (Fig. 1C). In addition, previous reports have shown that inhibition of the proteasome disrupts nucleolar assembly features, in keeping with its proposed role in proteostasis (Latonen et al., 2011, Moore, 2013, Frottin, 2019). Consistent with these observations, we found that exposure to the proteasomal inhibitor MG132 decreased NPM1 mobility by ~1.4-fold (Fig. 1D). Lastly, recent work has demonstrated that cellular stress can lead to rigidification of the nucleolus (Szaflarski, 2022). Therefore, we treated our cells with sodium arsenite and found a ~1.3 fold decrease in mobile fraction (Fig. 1D). Together, these results demonstrate that HiT-FRAP enables automated FRAP measurements of NPM1 that robustly report on perturbations to dynamics.
Systematic identification of factors that impact NPM1 dynamics
We next used HiT-FRAP to systematically identify factors that regulate NPM1 dynamics in the nucleolus. We focused initially on RNA helicases, which have been proposed to modulate condensate dynamics through their effects on RNA-driven phase separation (Hondele, 2019, Overwijn and Hondele, 2023, Linsenmeier, 2022, D et al., 02/06/2020). Many RNA helicases also localize to the nucleolus where they help coordinate ribosome biogenesis (Mitterer and Pertschy). Using an arrayed siRNA library, we depleted 65 RNA helicases and 9 phylogenetically related helicase pairs (Fig. S2A) in our mNeonGreen-tagged cell line and monitored NPM1 dynamics by HiT-FRAP. We identified 13 RNA helicases or helicase pairs whose depletion significantly affected t1/2, and 9 that altered mobile fraction (Fig. 2A, Fig. S2B). Hits were validated using de-pooled siRNAs and western blot for select targets (Fig. S2C and D) and reproduced in the mScarlet cell line (Fig. S2E). Because mobile fraction was less reproducible across replicates and cell lines, however, we focused subsequent analysis on factors affecting exchange kinetics.
Figure 2: HiT-FRAP identifies RNA helicases and RNA processing factors that impact nucleolar dynamics.

(A) Selected images and volcano plot of median robust z-scores (see Methods) for t1/2 for primary RNA helicase screen, highlighting helicase hits that resulted in increased (red, “slower”) or decreased (blue, “faster”) t1/2 relative to non-targeting control cells (yellow). Median values shown from three biological replicates. FDR < 0.05 and z-cutoff of ± 2.5 shown as dotted lines (see Methods). Non-significant gene targets shown in gray. Images are scaled equally and colored linearly with mp-inferno LUT to show NPM1 intensity. Scale bar is 10 μm. (B) Functional gene distribution of secondary screen by manual annotation. (C) Selected images and volcano plot as in (A) for secondary screen. (FDR < 0.05 and z-cutoff of ± 4, shown as dotted lines). (D) Gene enrichment for functional groups, determined by manual annotation, for “fast” (smaller t1/2) and “slow” (larger t1/2) hits.
Of the 13 helicases influencing t1/2, 8 are nucleolar or implicated in ribosome biogenesis (Fig. 2A). Helicases whose depletion accelerated recovery (DDX18 (Dembowski et al., 2013), DDX54 (Burger et al., 2000), DDX55 (Choudhury et al., 2021)) are involved in LSU assembly, while three of four helicases whose depletion slowed exchange (DDX41 (Chlon, 2021), eIF4A3 (Kanellis, 2021) and IGHMBP2 (de Planell-Saguer et al., 2009)) coordinate early rRNA processing through the SSU processome. The exception was co-depletion of DDX5 and DDX17, which remodel the LSU 28S rRNA (Jalal et al., 2007). Notably, these and other “slow” hits (AQR, DHX8, DHX38, eIF4A1+eIF4A2, UPF1) also function in pre-mRNA processing, NMD, and translation (Bohnsack et al., 2023), complicating interpretation of their nucleolar phenotypes.
Therefore, to distinguish direct from indirect effects, we designed a secondary screen of 290 gene depletions (Fig. 2B), comprising ribosomal proteins and assembly factors (51%) alongside STRING-database interactors of the helicase hits spanning diverse RNA processing pathways (Szklarczyk, 2023). This screen yielded 55 “slow” and 21 “fast” hits (Fig. 2C). Consistent with the primary screen, “fast” hits were enriched for LSU assembly factors and ribosomal proteins, suggesting that accelerated NPM1 exchange reflects broad disruption of LSU maturation (Fig. 2D). In contrast, “slow” hits were enriched for mRNA splicing, processing, and NMD pathways, which suggest that DDX5+DDX17, DDX41, eIF4A3, and IGHMBP2 likely influence nucleolar dynamics downstream of their non-ribosome biogenesis roles. Together, these screens reveal that NPM1 exchange is accelerated by disruption of LSU assembly and slowed by disruption of mRNA processing pathways.
Phenotypic clustering reveals four nucleolar biophysical states associated with distinct biological processes
Many perturbations that affected NPM1 dynamics also altered nucleolar morphology (Fig. 2A and C). We therefore reasoned that integrating these readouts may better distinguish biologically meaningful phenotypic classes than dynamics alone. We expanded our analysis to include morphological descriptors (mean intensity, area, circularity, and eccentricity) alongside dynamic measures (t1/2 and mobile fraction, Fig. 3A) and integrated these features using principal component analysis (PCA) to visualize phenotypic relationships across the dataset (Fig. 3A–C, Fig. S3A). Phenotype scores used in PCA incorporated both statistical significance and effect size relative to non-targeting controls to minimize false positive and batch effects (see Methods). Hits were defined by Euclidean distance from the NT cluster (top 15% cutoff) and reproducibility in at least two of three biological replicates (Fig. S3B). Phenotypes were largely consistent in mScarlet-tagged lines and p53-WT hTERT-RPE cells (Fig. S3C and D). Major morphological features were confirmed using orthogonal GC and DFC markers (Fig. S4A and B), gene knockdowns were assessed by qPCR (Fig. S4C), and bleach points were not impacted by morphological disruption (Fig. S4D). Phenotypes emerged within 24–48 hours of gene depletion, which suggests that they do not result from long-term growth defects (Fig. S4E).
Figure 3: Phenotype clustering identifies gene groups associated with specific nucleolar signatures.

(A) Schematic overview of phenotypic clustering analysis (see Methods). (B) PCA loadings for each nucleolar feature. (C) PCA colored by phenotype cluster. Schematic of nucleolar ribosome biogenesis stages shown on right, with phenotypic classes associated with stages indicated. (D) Hierarchical clustering analysis for hits (see Methods) using robust z-scores. Z-scores were scaled from 0 to 1. Clusters colored by phenotypic group. (E) Median scaled z-scores within phenotypic clusters for measured features. Dotted line shows median values for all hits that went into the analysis. (F) Representative images and FRAP curve for select hit in each phenotypic cluster. Images are scaled equally and colored with mpl-inferno LUT to show relative intensity differences in NPM1. White dotted line indicates nuclear boundary. Scale bar is 10 μm. FRAP curve of NT control and gene depletion shown (n = 250 nucleoli, error bars are 95% CI). Note, NT and NOG2 figure panels are replicated in Fig. 5A for comparison with LSU1 phenotype.
Grouping hits by function revealed that related genes clustered together in PCA space, forming four distinct phenotypic groupings, which we term nucleolar biophysical states (Fig. 3C and S4F). These groupings were validated by hierarchical clustering of phenotypic z-scores, which recovered similar gene clusters (Fig. 3D). Three of the four states were associated with other stages of ribosome biogenesis: early rRNA processing and transcription factors (“Early,” Fig. 3D–F), the RNA exosome, which coordinates rRNA end-processing throughout biogenesis (“RNA Exosome,” Fig. 3D–F), and factors involved in LSU assembly (“LSU,” Fig. 3D–F). Clustering analysis further subdivided the LSU group into two related sub-clusters (“LSU1” and “LSU2”, Fig. 3D). The fourth state (“Other,” Fig. 3D) comprised factors with no known role in ribosome biogenesis and included most “slow” hits identified by HiT-FRAP.
Notably, both PCA and hierarchical clustering of features revealed that certain dynamic and morphological features co-vary across the dataset, with faster NPM1 dynamics tracking with decreased NPM1 intensity, increased nucleolar size, and increased irregularity, and slower dynamics tracking with increased circularity and increased NPM1 intensity (Fig. 3B and D). This coherent covariance suggests that dynamics and morphology together report on the material state of the nucleolar condensate. Collectively, these analyses identify four nucleolar biophysical states that each reflect distinct biological processes, in particular stages of ribosome assembly.
Disruption of early rRNA processing steps results in nucleolar rounding and decreased NPM1 dynamics
Two of the four phenotypic states (“Early” and “RNA Exosome”) showed similar but distinct phenotypes consistent with previous reports (Neumüller, 2013). Both groups exhibited nucleolar shrinking and decreased NPM1 dynamics, while RNA Exosome depletions showed greater morphological irregularity (Fig. 3C–F). The “Early” gene group was composed of genes involved in rRNA transcription and early processing, while the “RNA Exosome” group contained nearly all core components of the RNA exosome, which coordinates 3′−5′ trimming of rRNA intermediates throughout ribosome biogenesis. However, we found that early rRNA processing factors in the 5′ETS particle, including UTPB and Sof1-UTP7 components, are also enriched in this cluster, which suggests that the observed phenotype may result from RNA exosome processing in early stages of ribosome assembly.
Early rRNA processing steps can be coupled with rRNA transcription, and therefore, we hypothesized these phenotypes occur downstream of transcription inhibition. In support of this idea, nucleolar shrinking and fragmentation was recapitulated by acute treatment with Pol I inhibitors ActD (0.04 μg/mL (Perry and Kelley, 1970, Perry and Kelley, 1968)) and CX5461 (Drygin, 2011) (500 nM) (Fig. S5A and B). Consistent with a role for pre-ribosome intermediates in maintaining nucleolar architecture, rRNA FISH using probes against the 5′ETS, ITS1, and ITS2 (removed during early/SSU-, SSU-, and LSU-associated maturation stages, respectively) revealed depletion of all rRNA precursors from the nucleolus under both PolI inhibition and knockdown of the core RNA exosome helicase SKIV2L2, with Northern blot confirming distinct processing defects for each condition (Fig. 4A, S6A and B).
Figure 4: Disruption of early rRNA processing leads to nucleolar disruption.

(A) rRNA FISH for Early (ActD) and Exosome cluster (knockdown of SKIV2L2). Schematic shows position of probes in 47S rRNA. Violin plots show spread of individual data points across three biological replicates (n = 600 nucleoli per replicate). Points represent means of replicates, error bars are SD of these means. The dotted line shows non-targeting control level. p-values calculated using two-tailed unpaired t-test between means of biological replicates. * p < 0.05, ** p<0.01, *** p < 0.001, **** p<0.0001. (B) “Other” phenotypic cluster shown as zoom of PCA in Fig. 3C. (C) Fold enrichment for functional groups in “Other” cluster. (D) Comparison between “Other” hit UPF2 and treatment with NMD inhibitor SMG1i (300 nM for 24 hr). Images are scaled equally and colored with mpl-inferno LUT to show relative NPM1 intensity differences. FRAP curves for NT/vehicle vs. gene depletion/SMG1i shown (n = 250 nucleoli, error bars are 95% CI). (E) Comparison between “Other” representative hit PHF5A and treatment with splicing inhibitor PladB (10 nM for 24 hr). Images are scaled equally and colored with mpl-inferno LUT to show relative intensity differences. FRAP curves for NT/vehicle vs. gene depletion/PladB shown (n = 250 nucleoli, error bars are 95% CI). (F) rRNA FISH for representative gene hits in “Other” phenotypic cluster, as in Fig. 4A. n.s. = not significant, * p < 0.05, ** p<0.01, *** p < 0.001
Interestingly, one of the clusters (“Other”) comprised factors with no known direct role in ribosome assembly, including members of the NMD pathway, the exon junction complex, and the SF3b spliceosome complex (Fig. 4B and C). This group showed reduced NPM1 dynamics and increased nucleolar intensity (Fig. 3D). We confirmed these phenotypes using inhibitors of the two most represented pathways, NMD (SMG1i (Gopalsamy, 2012)) and pre-mRNA splicing (PladB (Kotake, 2007)) (Fig. 4D and E, S5C–E). Despite their non-ribosomal functions, FISH revealed that depletion of SF3b factor PHF5A caused nucleolar accumulation of all three pre-rRNA intermediates, and Northern blot showed an increase in the 47S/45S/41S species, consistent with an early assembly stall (Fig. 4F, left, S6A and B). A similar but weaker effect was seen upon depletion of CNOT1, a core component of the CCR4-NOT deadenylase complex (Fig. 4F, right), suggesting that disruption of mRNA processing pathways converges unexpectedly on early ribosome biogenesis defects and accumulation of aberrant, early precursors in the nucleolus. Together, these results show that early rRNA processing is tightly coupled to nucleolar architecture, with loss of core early-processing/exosome activity driving nucleolar shrinkage via transcriptional inhibition, whereas disruption of seemingly unrelated mRNA-processing machinery instead causes aberrant accumulation of early pre-rRNA intermediates and nucleolar rigidification.
Disruption of key stages in late LSU maturation leads to nucleolar dispersion and increased NPM1 dynamics
The largest gene group we identified was enriched for factors that coordinate LSU maturation, consistent with the GC's primary role in LSU assembly (“LSU”). Knockdown of these genes increased nucleolar size and irregularity and decreased NPM1 t1/2, indicating disrupted condensate integrity and increased dynamics (Fig. 3C–F). These findings align with prior work from the Lafontaine group, which used a complementary nucleolar disruption index (iNo) built from morphological features and identified late-assembling LSU ribosomal proteins whose knockdown caused strong nucleolar disruption [35, 38, 39]. Several of their strongest hits (uL5, uL18, uL1, uL2, eL39, eL19) overlap with our LSU group, reinforcing our findings. Hierarchical clustering of our z-scores, however, resolved this group into two related but distinguishable subclusters, LSU1 and LSU2 (Fig. 3D, 5A). Both show increased nucleolar size, but LSU1 shows a more pronounced increase in area, while LSU2 shows a more irregular shape together with a substantial decrease in NPM1 intensity and t1/2, which suggests LSU2 may represent a more extreme version of LSU1. Consistent with this idea, LSU1 and LSU2 genes correspond to ribosomal proteins producing intermediate and strong phenotypes in the Lafontaine iNo dataset, respectively, suggesting these clusters may capture graded stages of nucleolar disruption.
Figure 5. Distinct nucleolar phenotypes are associated with discrete stages in large subunit biogenesis.

(A) Cropped heatmap from Fig. 3D showing LSU cluster split into two phenotypic clusters by hierarchical clustering (LSU1 and LSU2, respectively). Median feature z-scores for clusters shown in bar graph, where dotted line represents median z-scores across all hits that went into the analysis. Representative images and FRAP curves for of hits from LSU1 and LSU2 shown. Scale bar is 10 μm. Note, NT and NOG2 figure panels are replicated from Fig. 3F for comparison with LSU1 phenotype. (B) Mapping genes in LSU1 and LSU2 phenotypic clusters onto published structures of human LSU intermediates States F through H. Factors in LSU1 are colored green and LSU2 are colored teal. Major structural landmarks noted for reference. On State F, factors that are part of protein interaction network removed by MDN1 noted in pink. States G and H, both of which were partial reconstructions, are overlayed on transparent counterparts to show putative remainder of pre-LSU complex. PDB IDs: State F, 8FKY; State G, 8FKZ; State H, 8FL0. (C) rRNA FISH for representative hits in LSU1 (NSA2) and LSU2 (RPF2) gene clusters as in 4A. (D) Nucleolar immunofluorescence of LSU intermediate markers for depletion of LSU1 (NSA2) and LSU2 (RPF2) representative gene hits. Three biological replicates were performed (n = 600 nucleoli per replicate, spread of individual nucleoli shown as violin, error bars are SD). Points represent means of replicates, error bars are SD of these means. Dotted line shows non-targeting control level. p-values calculated using two-tailed unpaired t-test between means of biological replicates. n.s. = not significant, * p < 0.05, ** p<0.01, *** p < 0.001. (E) Nucleolar immunofluorescence for LSU intermediate marker NOG2 upon depletion of representative LSU2 hit NOP53. (Two biological replicates shown, n = 600 nucleoli per replicate, spread of individual nucleoli shown as violin, error bars are SD of replicate means). (F) Sucrose gradient (10–30% w/v) fractionation of nuclear pre-ribosomal complexes isolated from HeLa cells transfected with NOP53 or with control siRNA. (G) Western blot showing NOP53, NOG2, and NPM1 from pooled fractions as indicated. * = NPM1-mScarlet, ** = untagged NPM1. Right, quantification of LSU intermediate assembly factors from western blot that co-sediment with pre-LSU peak from two biological replicates. Normalized to the area under the curve for pooled fractions 6–9, then normalized to control. Two replicates shown, bar is mean.
To resolve what may lead to this graded phenotype, we mapped factors onto major events in pre-LSU maturation, drawing from mechanisms of ribosome biogenesis from previous work and structural characterization of human nucleolar (termed States A–H) and early nucleoplasmic (States I-L) LSU intermediates [16] (Fig. 5B). Both clusters localize to late nucleolar structural landmarks, but we find that LSU1 and 2 map to distinguishable steps within this window. LSU1 is enriched for ribosomal proteins that stabilize Domain III of the 28S rRNA, an event that occurs prior to nucleolar Stage F (Fig. 5B). LSU2, conversely, is enriched for factors that mature the central protuberance (CP), rotate the L1 stalk, and remodel the ITS2 foot ahead of cleavage, which are events associated with the States G/H and the transition to nucleoplasmic State I (Fig. 5B). Together, this mapping suggests that LSU1 and LSU2 might capture temporally distinct stalls in late LSU maturation, differentiated by the State F to G transition.
We therefore hypothesized that LSU1 and LSU2 phenotypes reflect nucleolar accumulation of stalled precursors at these distinct maturation points, consistent with reports that disruption of late LSU assembly in yeast causes accumulation of abortive intermediates (Gamalinda, 2014, Ohmayer et al., 2013 Jul 10). To test this idea, we first assessed nucleolar rRNA intermediate composition by FISH upon knockdown of representative genes from each cluster (LSU1: NSA2, which is necessary for 32S rRNA processing; LSU2: RPF2, which coordinates 5S RNP incorporation). Both cases caused significant nucleolar depletion of the 5′ETS and ITS1 and accumulation of ITS2 (Fig 5C, S6A), together with a global reduction in mature 28S by qPCR (Fig. S6C). Accumulation of ITS2 was confirmed in other genes from each group (LSU1: eL30, a Domain III ribosomal protein; LSU2: NOG2, a GTPase involved in late pre-LSU maturation and NOP53, which recruits the RNA exosome for ITS2 processing) (Fig. S6D), supporting that this is likely a shared signature across the phenotypic cluster. Northern blotting further confirmed accumulation of the 32S and 12S pre-rRNAs upon knockdown of RPF2 and NOP53 (Fig. S6B), indicating that ITS2 is cleaved but end-processing is impaired. Taken together, these results are consistent with a pre-export assembly stall.
The State F to G transition is marked by removal of an early assembly factor interaction network by the AAA-ATPase MDN1, allowing for binding of downstream factors that prevent reassociation of early assembly factors. To determine where LSU1 and 2 stall within this transition window, we performed immunofluorescence (IF) using markers for pre- and post-MDN1 removal states. For early pre-LSU States C-F, we used NOP2, an rRNA methyltransferase that is part of the removed assembly factor network (Fig. 5B). For later pre-LSU States G and H, we probed NOP53 and NOG2, which bind after network removal (Fig. 5B). Knockdown of the LSU1 genes NSA2 and eL30 caused nucleolar enrichment of NOP2, and for eL30, nucleolar depletion of NOP53 and NOG2, which suggests that intermediates upstream of the F to G transition accumulate (Fig. 5D, S6E and F). For NSA2 knockdown, however, we did see a modest nucleolar accumulation of NOG2, which indicates that these intermediates may retain the capacity to recruit downstream factors, as seen previously in yeast (Biedka, 2018). In contrast, knockdown of the LSU2 factor RPF2 caused strong nucleolar depletion of NOP2 accompanied by enrichment of NOP53 and NOG2 (Fig. 5D, S6E), which supports accumulation of later, State G/H intermediates. Knockdown of NOG2 and NOP53 themselves produced a similar G/H signature (Fig. 5E and S6F). To determine if these factors are part of developing pre-LSUs and not an unbound population, we performed sucrose gradient sedimentation of nuclear pre-ribosomes upon knockdown of NOP53. We found that NOG2 is not enriched in soluble fractions and instead co-sediments with pre-LSUs, confirming that the IF factors we observe are part of developing intermediates (Fig. 5F and G). Further confirming our results, previous biochemical studies in yeast have shown that perturbation of Domain III ribosomal proteins (i.e. LSU1) leads to accumulation of factors upstream of State F, while conversely, disruption of later ribosomal proteins associated with the LSU2 cluster led to accumulation of G/H factors (Ohmayer et al., 2013 Jul 10, Gamalinda, 2014).
Together, these results suggest that depletion of LSU1 and LSU2 genes stall pre-LSU maturation at distinguishable points along the late assembly pathway, with LSU1 stalling upstream of the F to G transition and LSU2 at States G and H (Fig. 5B). These stalls appear to result in nucleolar accumulation of distinct late abortive intermediates in the nucleolus. Importantly, this temporal difference is matched by the magnitude of nucleolar disruption, which indicates that the biophysical features of the GC are sensitive to this maturation window. Further work will be needed to more precisely resolve the identity of the stalled intermediates accumulating in each cluster and how their specific molecular features contribute to nucleolar disruption.
NPM1 dynamics and nucleolar partitioning are determined by interactions with developing pre-ribosomes
Across phenotypic clusters, the coherent covariation of NPM1 dynamics and nucleolar morphology suggests that both readouts report on a shared physical property: the strength of interactions that hold the condensate together. Current models in the field suggest that nucleolar condensation is driven by trans interactions between NPM1 and surfaces on ribosome intermediates, in particular rRNA and IDRs. The valency of trans interactions is thought to decrease as the ribosome matures, ultimately supporting thermodynamic flux of the ribosome out of the nucleolus (LaPeruta et al., 2022, Riback, 2020). We therefore hypothesized that the strength of interactions between NPM1 and developing pre-ribosomes determines condensate cohesion and scaffold dynamics. In support of this idea, we observed a strong direct correlation between NPM1 partitioning into the nucleolus from the nucleoplasm (see methods) and t1/2 for representative hits across fast and slow phenotypic clusters (Fig. 6A, r = 0.87, p = 0.0001). This trend suggests that conditions that drive stronger partitioning into the condensate also slow NPM1 exchange, while conditions that weaken partitioning accelerate it. Furthermore, increased irregularity (as measured by decreased circularity and increased eccentricity) correlated with shorter t1/2 across clusters (Fig. 3D), linking disruption of condensate integrity to faster molecular exchange. Together, these observations support a hypothesis that the valency of NPM1-pre-ribosome interactions sets the material state of the nucleolus by determining simultaneously how cohesive the condensate appears morphologically and how dynamically its scaffold exchanges.
Figure 6: NPM1 dynamics are determined by interactions that drive partitioning into the nucleolus.

(A) Partition coefficients vs. t1/2 for representative hits in phenotypic clusters (n = 100 nucleoli, points are mean, error bars are SD). Purple circles = representative Other” hits. Teal circles = representative “LSU” hits. Pearson r and p-value indicated. (B) Sucrose gradient fractionation of pre-ribosomal complexes from nuclear fraction of HeLa cells transduced with NPM1WT-mScarlet. Bottom left, western blot for indicated proteins shown below for pooled fractions. Ethidium bromide-stained RNA gel for total RNA isolated from indicated pooled fractions shown to bottom right. Approximate size of 28S and 18S indicated. Note, these panels are also shown in Fig. S7F. (C) Schematic of NPM1 mutant constructs. Each construct is also N-terminally fused with mScarlet. Gray box represents charge neutralization. Yellow lines represent annotated nuclear localization signal (NLS). Representative images shown for localization pattern of each mutant construct (mScarlet signal). Dotted line outlines nucleus. Scale bar is 10 μm. (D) Left: representative western blot for ribosome assembly factors and proteins associated with immunoprecipitated NPM1 with indicated mutations. Northern blot for ITS2 showing 32S band shown at bottom. Right: Quantification of blots from IPs across replicates. Error bars are SD. n = 3 independent experiments. (E) Sucrose gradient fractionation of nuclear pre-ribosomal complexes isolated from HeLa cells transduced with NPM1WT-mScarlet (blue curve), NPM1mA3-mScarlet (orange curve), and NPM1mB2-mScarlet (yellow curve). Below, western blot showing mScarlet-tagged (RFP antibody) NPM1 from pooled fractions as indicated. Quantified ratio of RFP signal normalized to WT shown below each mutant blot. Note, this data is also shown in Fig. S7F. (F) Partition coefficients for each mutant construct. Violin plot shows spread of individual points for 3 biological replicates (n = 40 nucleoli per replicate, points show means of each replicate, error bars are SD). p-values calculated using two-tailed unpaired t-test between means of biological replicates. * p < 0.05, ** p<0.01, *** p < 0.001. (G) t1/2 for each mutant construct. Violin plot shows spread of individual points for 3 biological replicates (n = 250 nucleoli per replicate, points show means of each replicate, error bars are SD). p-values calculated using two-tailed unpaired t-test between means of biological replicates. n.s. = not significant, ** p<0.01, *** p < 0.001.
To directly test whether NPM1-preribosome interactions dictate dynamics, we performed sucrose gradient sedimentation and found that NPM1 preferentially co-sediments with pre-LSU complexes (Fig. 5F and 6B), consistent with prior reports (Okuwaki et al., 2021). To ask how assembly state affects this association, we examined NOP53-depleted cells, where late LSU intermediates accumulate and NPM1 dynamics are accelerated (Fig. 5E–G). We found that NPM1 cosedimentation with the pre-LSU peak is markedly reduced in this context (~75% decrease as compared to control, Fig. 5G), consistent with the prediction that late LSU intermediates, which have undergone partial rRNA folding and factor displacement, present fewer NPM1-binding surfaces. This result links the assembly state of pre-ribosomal particles directly to NPM1 association strength, supporting the idea that ribosome maturation progressively reduces the valency of condensate-scaffold interactions.
We then sought to identify the molecular features of NPM1 that mediate this maturation-sensitive association and thereby determine scaffold dynamics. NPM1 contains an N-terminal pentamerization domain, an IDR linker, and a C-terminal RNA-binding three-helix bundle (Fig. 6C). The IDR exhibits a charged block pattern, where two acidic domains (A2 and A3) that mediate heterotypic interactions with positively charged nucleolar IDRs alternate with two basic regions (B1 and B2) that bind to rRNA (Mitrea, 2016). Homotypic interactions between A3 and B2 can also drive phase separation (Ferrolino et al., 2018), although these appear to contribute less strongly to partitioning than heterotypic interactions (Riback, 2020). To determine how these domains contribute to the interactions between NPM1 and pre-LSU complexes, phase separation, and dynamics in cells, we generated lentiviral constructs with mScarlet-tagged NPM1 where we charge neutralized each IDR region (NPM1mA2, NPM1mB1, NPM1mA3, and NPM1mB2, see Fig. 6C and Methods) and introduced them into unedited HeLa cells. To eliminate the contribution of heteropentamer formation with endogenous WT NPM1, we also introduced constructs into HeLa cells where endogenous NPM1 was stably ablated (Fig. S7A–C).
We assessed mutant interactions with pre-LSU complexes by co-IP western blot, qPCR, and ITS2 Northern blot, as well as sucrose gradient co-sedimentation. Mutation of A3 increased association with markers of pre-LSU intermediates and the 32S pre-rRNA as well as co-sedimentation with pre-LSU complexes, while loss of B2 led to decreased association (Fig. 6D and E and S7D–F). These impacts were strengthened in the absence of WT NPM1 (Fig. 6D and S7D–F). The increased preribosome association upon A3 removal supports in vitro findings that intramolecular A3/B2 interactions tune the availability of B2 for heterotypic rRNA binding, potentially acting as a regulatory switch (Ferrolino et al., 2018), and demonstrates that B2 is the primary driver of preribosome association.
Having established that IDR mutations directly tune NPM1-preribosome interactions, we asked how this impacts partitioning and dynamics. In the presence of endogenous NPM1, NPM1mA2 and NPM1mB1 showed modest decreases in nucleolar partitioning (~30% and ~20%, respectively) (Fig. 6F), consistent with loss of heterotypic interactions with R-rich proteins and rRNA. Neutralization of A3, however, increased partitioning by ~30%, while loss of B2 caused a ~75% decrease, with NPM1mB2 largely excluded from the nucleolus in the knockout background (Fig. 6F, S7C). Strikingly, these changes in partitioning were directly reflected in NPM1 dynamics (Fig. 6G). The strongly partitioning construct NPM1mA3 showed a ~20% increase in t1/2, while NPM1mA2 and NPM1mB2, which partitioned more weakly, exhibited significantly faster recoveries (~20% and 40%, respectively). These results directly correlate with NPM1-preribosome interaction strength (Fig. 6E). Together, these results demonstrate that the strength of NPM1-preribosome interactions determines both nucleolar partitioning and scaffold exchange dynamics (Fig. 7A), providing a mechanistic basis for the changes in dynamics and morphology we observe across phenotypic clusters in our screen.
Figure 7: Model for coupling ribosome assembly to nucleolar dynamics.

(A) Model for how ribosome intermediates determine nucleolar biophysical properties. Insets show how regions of the NPM1 IDR influence interactions with ribosomal precursors. Heterotypic interactions with surfaces on developing pre-ribosomes (represented by teal ball) shown as teal dotted line, homotypic interactions between A3 and B2 shown as red dotted line. (B) Model for pre-ribosomal maturation at the GC interface as it relates to nucleolar dynamics and precursor valency. Uncompacted IDRs (teal lines) and rRNA (gray lines) indicated graphically, with progressive loss over maturation.
Discussion
Here, we use HiT-FRAP to show that NPM1 dynamics and nucleolar morphology are jointly sensitive to the assembly state of ribosomal precursors, and that this sensitivity reflects the strength of NPM1-preribosome interactions. Conditions that drive accumulation of high-valency early intermediates simultaneously slow NPM1 exchange and compact the condensate, while accumulation of low-valency late LSU intermediates accelerates exchange and disrupts condensate integrity. Importantly, mutations in the NPM1 IDR that strengthen pre-ribosome binding slow exchange and increase partitioning, while those that weaken binding accelerate exchange and reduce partitioning, providing direct mechanistic support for this model. Together, these findings demonstrate that the interaction networks driving nucleolar phase separation also determine the dynamic and morphological properties of the condensate, connecting ribosome assembly state to nucleolar material properties at the molecular level.
Insights into nucleolar condensate biophysics and assembly principles
Our results support a physical picture where nucleolar scaffold dynamics and morphology are determined by the strength of heterotypic interactions that drive condensate formation, as seen in other network fluids and in vitro reconstituted condensate systems (Alshareedah et al., 2021, Dias et al., 2017). Importantly, this finding indicates that the nucleolus does not behave as a simple fluid, which was historically inferred from studies using NPM1 as a proxy for liquid-like nucleolar behavior. This highlights a key question: how do individual nucleolar components contribute to the physical features of the condensate, and how do those features shape condensate function? Indeed, it was recently shown that nucleolar proteins are substantially more dynamic than the rRNA gel they surround (Riback, 2023), consistent with the idea that a kinetically accessible environment facilitates chaperone-mediated rRNA folding and the sequential assembly factor exchanges required for modular maturation. Our results suggest that this kinetic accessibility may be set, at least in part, by the valency networks driving phase separation, which likely influence assembly factors beyond NPM1. Systematically mapping how the dynamics of other nucleolar constituents relate to their function and to overall condensate material properties will be an important future direction.
Connecting nucleolar assembly principles to ribosome assembly
Interestingly, it has recently been demonstrated that the nucleolus exhibits non-uniform material properties radially, with a more solid-like core and more liquid-like periphery (Cheng et al., 2025). Our results suggest a molecular basis for this gradient, where the valency of interactions between nucleolar scaffolds such as NPM1 and developing ribosomes dictate condensate material properties: less assembled precursors participate in more interactions with NPM1 to create more solid-like features, while more assembled intermediates are more compact and thus have less interfaces available for binding, resulting in increased fluidity. We hypothesize that the nucleolar surface most closely represents the liquid-like system represented in current NPM1-based nucleolar reconstitution systems. Therefore, we propose that NPM1 dynamics may most strongly impact late subunit maturation and nucleolar export at this interface, discussed below.
Consistent with previous results (Nicolas, 2016, V et al., 2018 Oct, Okuwaki et al., 2021, Zorbas et al., 2024), we find that disruption of late LSU assembly leads to nucleolar accumulation of late abortive intermediates, likely human States G/H, which weakens the nucleolar condensate and leads to disrupted morphology and increased NPM1 exchange. We therefore propose that the human State G/H intermediates represent the final stages before export, where the transition to State I licenses release by falling below the threshold of valency required for nucleolar sequestration. This transition is hallmarked by installation of the CP coupled with binding of the rixosome, a complex necessary for ITS2 processing. Trans interactions may change in several ways during this transition. Several IDRs are lost or stabilized, although in total, IDRs increase due to arrival of rixosome components (Fig. S7G). More notably, domains IV and V of the 28S rRNA mature, collectively resulting in a ~30% decrease in uncompacted rRNA (Fig. S7G). This mechanism appears to be conserved, as recent work in yeast identified a similar LSU intermediate as the final nucleolar assembly stage (LaPeruta, 2023). However, intriguingly, engineered rRNA that lacked large portions of ITS2 and 28S expansion segments did not globally impact ribosome export, despite being comparable in size to the compaction of the 28S that occurs during the transition to State I (Sarkar, 2017, Rodríguez-Galán et al., 2015, Broeck and Klinge, 2023–07–07). These findings suggest at least two possibilities: 1) that certain “uncompacted” rRNA regions may not be available for trans interactions, or 2) that additional factors outside of these interactions may govern sequestration within the nucleolus and export to the nucleoplasm. Therefore, further work characterizing export incompetent intermediates will be necessary to understand the structural mechanism for nucleolar release.
We also identified a small subset of SSU proteins whose depletion leads to a similar phenotype as the LSU genes (uS19, uS15, uS17, eS25, and eS26). While these genes lack obvious functional coherency, their impact on the nucleolus may reflect a role for these proteins in SSU maturation within the GC. Indeed, previous work has shown that eS26 directly interacts with NPM1 (AV et al., 2018 May–Jun). Moreover, although much of SSU maturation occurs in the DFC, the SSU transits through the GC before export to the nucleoplasm, which suggests that some quality control of the SSU may occur in the GC. Exploring the interplay between SSU and LSU maturation within the GC will be an important area for future study.
Taken together, we propose that the biophysical features and ribosomal intermediates associated with the “LSU” group represent the outermost molecular “layer” of the nucleolus, providing biophysical insight into the nucleolar interface (Fig. 7B). This idea is supported by recent in situ structural efforts in Chlamydomonas nucleoli that revealed a gradient of ribosome assembly intermediates at the nucleolar surface (Erdmann, 2021). Importantly, interfaces are a unique environment where the condensate and its surroundings meet, and as such, have been shown to form distinct chemical and functional environments in other condensate systems (Farag, 2022, Folkmann et al., 2021, Zhang, 2023). In the case of the nucleolus, the final stages of precursor assembly must interact with the nuclear environment, which could influence these steps in nontrivial ways. Consistent with this idea, it has been shown that disruption of chromatin structure leads to amorphous nucleolar morphology reminiscent of the LSU phenotype (Riback, 2023, Schichler et al., 2026–03–24). It is therefore likely that the nucleolar interface possesses specialized features to facilitate handoff. In support of this hypothesis, recent work has shown that the nucleolar rim is a compositionally distinct compartment, and intriguingly, is enriched for NPM1, factors removed in the State F to G transition (BOP1, DDX18, EBP2, FTSJ3, NOC2L, NOC3L), State G/H factors (NOG2, RPF2, uL18), and factors involved in remodeling of State G/H to I (GNL3, CCDC86) (Stenström, 2020). It will be exciting to consider how the unique environment of the nucleolar interface may facilitate the key molecular events associated with these architectural changes, while remaining distinct from the nuclear surroundings.
Lastly, we speculate that nucleolar assembly principles could be linked to ribosomal quality control. We believe our results support the thermodynamic gating model previously proposed in the literature (Riback, 2020, Laperuta et al., 2023, LaPeruta et al., 2022), where only properly assembled intermediates that have undergone the compaction and remodeling necessary to fall below a critical valency threshold are competent for export, while aberrant or stalled particles remain sequestered. Importantly, our results suggest that the liquid-like character of the nucleolar surface may be essential for this gate to function, by ensuring that export-competent particles can traverse the interface on biologically relevant timescales rather than remaining kinetically trapped, while incompetent particles remain in the interior.
Biophysical changes in the nucleolus in response to stress
We also discovered unexpected ties between nucleolar dynamics and mRNA processing pathways. Connecting our observations to reports in the literature suggest that they may relate to the nucleolus’s role in cellular stress responses. For example, rRNA processing stalls during acute stress and leads to accumulation of unprocessed precursors, which decrease nucleolar dynamics and are stored until stress is alleviated (Szaflarski, 2022, Darriere). Furthermore, during stress, the nucleolus reversibly stores misfolded proteins whose aggregation is prevented through interactions with scaffolds such as NPM1, leading to nucleolar rigidification (Frottin, 2019). Therefore, nucleolar dynamics may serve as a sensitive integrator of cellular homeostasis, with implications for diseases in which nucleolar function and RNA metabolism are co-disrupted, including ALS and FTD, where NPM1 dynamics, nucleolar stress, and RNA processing pathways are all perturbed (Corman et al., 2023, Nussbacher et al., 2019, Suzuki et al., 2018, Kwon, 2014).
Conclusion
Our work establishes that the assembly state of ribosomal precursors determines the material properties of the nucleolar condensate through the valency of interactions with the scaffold NPM1, connecting ribosome biogenesis to nucleolar biophysics at the molecular level. This model implies that the same interaction networks that drive phase separation also govern condensate dynamics, suggesting that material properties may be directly tunable by the composition and connectivity of condensate interaction networks (Sanders, 2020). This principle may be relevant to pathological condensates, where shifts in the stoichiometry of key interactors could drive transitions toward poorly dynamic, aggregated states (Shin and Brangwynne, 2017). More immediately, our findings raise the question of how NPM1 dynamics influence late LSU maturation and nucleolar export, which has direct relevance to diseases that disrupt nucleolar interaction landscapes. More broadly, our results raise the possibility that condensate material properties are not merely downstream consequences of the interactions they house but are themselves part of the functional machinery, actively shaping the kinetic landscape of the processes they organize. HiT-FRAP now provides a platform for testing this principle systematically, both in the nucleolus and across other biomolecular condensates whose dynamic properties remain mechanistically uncharacterized.
The data are available from JS-G upon request.
Materials and Methods
Cell culture
HeLa (cTT20.11 (McKinley and Cheeseman, 2017), gift from Kara L. McKinley and Iain Cheeseman) and Lenti-X HEK293T cells (Takara Bio, used for lentivirus production) were cultured in DMEM (Gibco) supplemented with 10% tetracycline-free FBS (Gemini) and penicillin and streptomycin (Gibco) at 37°C with 5% CO2 in a humidified incubator. Cells were maintained at passage number under 25 and routinely checked for mycoplasma. Cells were passaged using 0.05% Trypsin-EDTA (Gibco).
Endogenously-tagged cell line generation
Endogenously-tagged cell lines were generated using CRISPR-Cas9 homology directed repair. Guide RNAs targeting the last exon of NPM1 and FBL were designed using the Benchling CRISPR tool to maximize on-target and minimize off-target effects (targeting sequence: NPM1-GCCAGAGATCTTGAATAGCC; FBL-AACTGAAGTTCAGCGCTGTC). This sequence was inserted into pX330 (gift of Feng Zhang, Addgene #42230), which encodes both spCas9 and the sgRNA. Homology arms for genes of interest were ordered from IDT as gBlocks with PAM sequence for sgRNA mutated. Homology arms were cloned into pKLM73 for mNeonGreen and pKLM110 for mScarlet (gifts from Kara L. McKinley) using NEBuilder HiFi DNA Assembly (New England Biolabs). To generate knock-in lines, HeLa cells were seeded in a 6-well plate at 1×106 cells per well. The following day, cells were transfected with 1 μg each of the pX330 and donor plasmids using Lipofectamine 2000 (ThermoFisher). After 72 hr, cells were passaged into 10 cm dishes and cells with integration were selected for using puromycin at 1 μg/mL. After sufficient cell death and outgrowth of resistant colonies, cells were passaged one additional time to recover and then fluorescently positive cells were sorted for single cells into a 96-well plate using a Sony SH800 cell sorter. Single-cell clones were checked for correct localization of tagged protein and confirmed by genotyping PCR. Briefly, gDNA was isolated from a confluent 12-well plate by rinsing once with PBS followed by addition of 0.5 mL genomic DNA lysis buffer (100 mM Tris pH 8, 5 mM EDTA, 200 mM NaCl, 0.2% SDS, 0.2 mg/mL proteinase K). Plates were incubated with lysis buffer at 37°C overnight. Lysed cells were transferred to an Eppendorf tube and DNA was precipitated using isopropanol followed by washing with 70% ethanol. Pellet was resuspended in TE buffer (1 mM EDTA pH 8, 10 mM Tris pH 8) and used as a template for amplification of insertion regions. Products were visualized for size differences by agarose gel and then gel purified and submitted for Sanger sequencing.
Knockout cell line generation
NPM1 was stably ablated from HeLa cells (cTT20.11) using CRISPR-Cas9 as follows. Gene Knockout Kit v2 against NPM1 from Synthego was used for guide RNAs. 180 pmol guides were complexed with 20 pmol EnGen Spy Cas9 NLS (New England Biolabs) for 10 min at room temperature. The assembled Cas9 RNP was nucleofected into 1.5 × 105 cells using Lonza 4D-Nucleofector X unit and SE Cell Line Kit following manufacturer’s protocol. Polyclonal population was assessed for knockdown by western blot and then sorted into single cells using a SONY SH800. Single cell clones were assessed for knockdown by western blot against NPM1 and Sanger sequencing.
Microscopy
All live-cell and fixed-cell confocal imaging was carried out on a Nikon Ti-E inverted microscope equipped with a Yokogawa CSU-X high-speed confocal scanner unit and a pair of Andor iXon 512 × 512 EMCCD cameras. All components of the microscope were controlled by the open-source platform μManager (Edelstein, 2014). The microscope stage was enclosed in a custom-built incubator that maintains preset temperature. Live-cell imaging was performed at 37°C with 5% CO2 and cells were equilibrated on the microscope for at least 30 min prior to imaging. Cells were imaged in complete culture media (DMEM, 10% FBS, penicillin/streptomycin). Fixed-cell imaging was performed at room temperature. High-magnification images were obtained using a 100× 1.49 NA oil-immersion objective. HiT-FRAP and high-content images were acquired with a 40× 0.95 NA air objective. For HiT-FRAP, images for mNeonGreen cells and mScarlet cells were collected at 100x EM gain with a 50 ms and 100 ms exposure, respectively. Bleaching was performed with a 405 nm focused laser beam set at 10 mW power steered by a pair of galvo mirrors (Rapp UGA-40), which was controlled by the Projector Plugin in μManager.
HiT-FRAP acquisition
Automated FRAP experiments were performed using custom code and the Python library Pycromanager (Pinkard, 2021), which integrates hardware control with image processing via μManager. Image processing was performed using scikit-image (van der Walt, 2014). Positions and wells for acquisition were defined using the μManager High Content Screening (HCS) Site Generator Plugin. Exposure length was predetermined for each cell line to avoid saturated pixels. HiT-FRAP acquisition proceeded as follows: at each field of view, a single image was acquired. Organelles of interest were then identified. Firstly, the background pixel threshold was determined using Otsu’s method. Threshold values for nucleoli were determined using local thresholding, and regions larger than 1000 pixels were removed. Both thresholds were combined and then subjected to two rounds of erosion and dilation, followed by removal of objects smaller than 10 pixels to clear the background. To maximize throughput, further analysis and acquisition only continued if greater than 20 organelles were present in a field of view. Centroids for organelles were then determined to generate a bleach position list. We set a size threshold for bleached organelles of at least twice the area of the bleach spot to preferentially capture internal mixing rather than exchange with the nucleoplasm, although due to limitations in magnification and the fixed size of our bleach laser, whole-organelle bleaches could not be completely avoided. A random 50% of these positions were then chosen for bleaching, with the remainder kept as controls to account for acquisition photobleaching. Bleach locations were exported for every field of view to be used in post-analysis. Acquisition then started, followed by concurrent bleaching at designated organelle centroid positions. Length of acquisition was manually pre-determined to achieve recovery plateau. This process was iterated through multiple fields of view until 500 bleaches were acquired, after which the stage was moved to the next well and the sequence repeated.
To account for drift in the bleach laser position, automated recalibration was performed as follows: after every two fields of view, a single image was acquired. The image was thresholded to identify cells using the triangle algorithm, and a position closest to the center that did not have a foreground object (cell) was determined. The bleach laser was then targeted to this location and an image was taken of the exposure. The true bleach laser position was determined from this image by identifying the maximum intensity position in the image. To increase the speed of finding this location, a region of interest was used based upon the estimated location of the bleach laser. When the square of the distance between the intended target and the true bleach spot location was greater than an offset of 5, a full calibration of the laser was performed.
HiT-FRAP image analysis
Analysis of high-content FRAP data was performed using the same software used for acquisition. For each FRAP recovery time series, nucleoli were identified in frame 0 using the same thresholding procedure as used for acquisition. Bleach spots were then identified as follows: the bleach positions generated during acquisition (pointers) were linked to the bleach frame. To account for experimental offsets in bleach positions, true bleach locations were determined empirically. Briefly, it was manually determined that the minimum intensity post-reported bleach time occurred after four frames (bleach time offset). For each pointer position, the minimum intensity frame (bleach frame + bleach time offset) was subtracted from the bleach frame and smoothed to remove background noise. Otsu global thresholding was then applied to identify bright spots (detected bleach spots). After two rounds of erosion and dilation to minimize background noise, the centroids of the closest detected bleach spots to each original pointer position were used as the true bleach location. These true bleach coordinates were then linked to the corresponding organelle. Bleach spots that fall outside of a nucleolus, bleach the same nucleolus, overlap, or are too far away from the original pointer position (>20 pixels in any direction) were filtered. Bleach spot masks were then generated by subjecting the true bleach coordinates to three rounds of dilation.
Using these bleach spot masks, FRAP curves were determined as follows: to monitor photobleaching due to acquisition, control spot masks were generated by identifying centroids of unbleached organelles and submitting these to three rounds of dilation. Raw intensities for the bleach and control spots were calculated over the time course. Background was determined for each frame by generating a binary image of regions with a pixel intensity of less than 300, removing regions smaller than 50 pixels. The mean intensity of the largest area was used as background and subtracted from all measured intensities. A photobleaching factor was then determined for control spots and calculated as the intensity ratio between the control spot at every time point as compared to intensity at t = 0. The mean of this ratio across all control spots was then used as a correction factor for bleach spot intensities. These intensities were then normalized to the pre-bleach intensity and minimum intensity (0 to 1) to generate final intensities for fitting. These intensities were then fit to several FRAP models (single exponential, double exponential, soumpasis, and ellenberg), although single exponential fittings were used in all subsequent analyses. Curves were filtered out if they had less than 5 frames prior to bleach (to avoid poor determination of pre-bleach intensity), imaged for less than 100 frames post bleach for mNeonGreen or 50 frames for mScarlet (to ensure adequate recovery), if the mobile fraction was less than 0 or greater than 1.05, and if R2 < 0.7. Parameters from the fitted curve are then exported (initial slope, mobile fraction, and t1/2).
Organelle features were determined as follows: for each bleached nucleolus, the following organelle features available in scikit-image were calculated: area, mean intensity, circularity, eccentricity, solidity, minimum intensity, maximum intensity, perimeter, hu moments (2nd, 3rd, and 4th), intensity percentiles (1st, 5th, 95th, and 99th), median intensity, the standard deviation of intensities, intensity kurtosis, and intensity skew.
Analysis code for HiT-FRAP acquisition and analysis is publicly available on GitHub (https://github.com/jess-sheu/colony_blob_bleacher) and archived on Zenodo (https://doi.org/10.5281/zenodo.20275447).
Dynamics screen phenotype analysis
Gene depletions with high cell death were removed manually from all subsequent analysis (DDX19B, DDX19A+DDX19B, DDX39A+DDX39B, and SNRNP200, CRNKL2, CWC22, EFTUD3, eS4, eS6, PRPF8, SNW1). Dynamics features (mobile fraction and t1/2) were normalized using the median and median absolute deviation for all non-targeting siRNA controls in the same plate to account for plate-to-plate variation (robust z-score). Medians of robust z-scores were computed and used in final hit calling. p-values were calculated using the Kolmogorov-Smirnov test as compared to a randomly chosen subset (10%) of non-targeting control wells. FDR was determined using the Benjamini-Hochberg procedure. As indicated in the figure legends, an FDR threshold of 0.05 was used for defining significance. Thresholds for z-scores were set as indicated in figure legends.
Principal component analysis for multidimensional analysis
Phenotype scores were calculated and incorporate the −ln(p-value) (determined by Kolmogorov-Smirnov test) and effect size as compared to a subset (randomly selected 10%) of non-targeting control wells in the same plate to account for plate-to-plate variation. The remainder of non-targeting controls were treated as experimental samples to test the robustness of the scoring method. Phenotype scores were scaled from 0 to 1 prior to further analysis. PCA was performed using the prcomp R package. The R packages ggplot2 (Wickham), ggfortify (Tang et al., 2016), and ggrepel (Slowikowski, 2023) were used to generate figures and are available through CRAN. Hits were manually called by separation from NT control cluster.
Hierarchical clustering to identify phenotype clusters
Robust z-scores for hits were used in hierarchical clustering using the pheatmap R package (Kolde, 2019) by Ward’s minimu variance method, variant D2. The resulting dendrogram was split into subtrees until clusters represented similar overall trends, generating five phenotypic clusters shown in Fig. 3D.
Cloning for mutant NPM1 lentivirus constructs
All constructs were cloned into the lentiviral transfer plasmid pKLM79 (gift of Kara L. McKinley), which contains a C-terminal mScarlet fusion tag. The wild-type sequence of NPM1 was cloned from GFP-NPM WT (gift from Xin Wang, Addgene plasmid # 17578). Mutant NPM1 plasmids were constructed by ordering mutated regions as gBlocks from IDT with overhangs complementary to proximal regions. Proximal regions were then amplified from the wild-type construct to generate fragments with appropriate overhangs for assembly by NEBuilder HiFi DNA Assembly (New England Biolabs) into pKLM79 (cut with MluI and SpeI, New England Biolabs).
Lentivirus transduction
Lentiviral particles were packaged by transfecting Lenti-X 293T cells with transfer construct of interest and PSP and VSVG helper plasmids using Lipofectamine LTX (Thermo Fisher) reagent. Media was changed 18 hr later and virus was harvested 72hrs after transfection. Virus was cleared by passing through a 0.45 μm PVDF filter. 200 μL viral supernatant was used to transduce a 6-well plate of HeLa cells by spinfection. Briefly, cells were seeded in suspension at 250,000 cells per well in the presence of viral supernatant and polybrene (Sigma-Aldrich) at a final concentration of 10 μg/mL. Cells were spun at 1000 x g for 45 min at 37°C and allowed to recover overnight. Media was replaced the following day and transduction was allowed to proceed for 48 hr until passage. Cells were passaged for at least two passages to eliminate cells that exhibited toxic levels of expression. Fluorescent cells were sorted using a Sony SH800 cell sorter gated to select the top 40% of expressing cells. Polyclonal populations were used for all experiments.
siRNAs
For the primary RNA helicase and secondary screen, candidate libraries of ON-TARGETplus SMARTPool siRNAs (4 guides per gene) were ordered in arrayed format from Horizon Discovery. Non-targeting siRNA pools were interspersed randomly throughout the plate at a ratio of 1:6 to on-target pools. For depooled validation, deconvoluted guide pools (single guides) were ordered in an arrayed format for select hits. Single non-targeting guides were interspersed randomly throughout the plate at a ratio of 1:6. For knockdown of single genes, ON-TARGETplus siRNA pooled guides were ordered from Horizon Discovery (see Key Resources Table).
Key resources table
| Reagent or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Cell line (human) | HeLa cell line with inducible Cas9 (cTT20.11) | Gift from Kara L. McKinley and Iain Cheeseman (McKinley and Cheeseman, 2017) | N/A | Parent cell line used for NPM1-tagged reporter cells |
| Cell line (human) | Lenti-X HEK 293T cells | Takara Biosciences | Cat# 632180 | For lentivirus production. |
| Cell line (human) | NPM1mNeonGreen HeLa | This paper | N/A | Tagged at endogenous locus. Lab ID: cJSG169.21 |
| Cell line (human) | NPM1-mScarlet HeLa | This paper | N/A | Tagged at endogenous locus. Lab ID: cJSG26.1 |
| Cell line (human) | NPM1WT-mScarlet HeLa | This paper | N/A | Lab ID: cJSG224 |
| Cell line (human) | NPM1mA2-mScarlet HeLa | This paper | N/A | Lab ID: cJSG226 |
| Cell line (human) | NPM1mB1-mScarlet HeLa | This paper | N/A | Lab ID: cJSG240 |
| Cell line (human) | NPM1mA3-mScarlet HeLa | This paper | N/A | Lab ID: cJSG228 |
| Cell line (human) | NPM1mB2-mScarlet HeLa | This paper | N/A | Lab ID: cJSG230 |
| Cell line (human) | NPM1 knockout HeLa | This paper | N/A | Lab ID: cJSG203.4 |
| Cell line (human) | NPM1WT-mScarlet in NPM1 knockout HeLa | This paper | N/A | Lab ID: cJSG213 |
| Cell line (human) | NPM1mA3-mScarlet in NPM1 knockout HeLa | This paper | N/A | Lab ID: cJSG234 |
| Cell line (human) | NPM1mB2-mScarlet in NPM1 knockout HeLa | This paper | N/A | Lab ID: cJSG236 |
| Construct/Plasmid | GFP-NPM WT | Gift from Xin Wang, (Wang. W et al., 2005) | Addgene # 17578 | Used to obtain sequence of NPM1-WT. |
| Construct/Plasmid | pX330 | Gift from Feng Zhang | Addgene # 42230 | |
| Construct/Plasmid | pKLM73, derived from pL452 (AK et al., 01/25/2019) | Gift from Kara L. McKinley | See (KL, 2018) | Donor plasmid with C-terminal mNeonGreen and puromycin resistance cassette. Used for cloning of NPM1 HDR constructs. |
| Construct/Plasmid | pKLM110, derived from pL452 (AK et al., 01/25/2019) | Gift from Kara L. McKinley | See (KL, 2018) | Donor plasmid with C-terminal mScarlet and puromycin resistance cassette. Used for cloning of NPM1 HDR constructs. |
| Construct/Plasmid | pKLM79 | Gift from Kara L. McKinley | Lentivirus transfer plasmid with C-terminal mScarlet Fusion tag. SFFV promoter. Used for cloning of NPM1 mutant constructs. | |
| Construct/Plasmid | NPM1mNeonGreen-PuroR donor plasmid | This paper | Lab ID: pJSG248 | |
| Construct/Plasmid | NPM1-mScarlet-PuroR donor plasmid | This paper | Lab ID: pJSG39 | |
| Construct/Plasmid | pX330-NPM1 sgRNA | This paper | Targeting sequence: GCCAGAGATCTTGAATA GCC. Lab ID: pJSG12 |
|
| Construct/Plasmid | SFFV-NPM1WT-mScarlet | This paper | Lab ID: pJSG288 | |
| Construct/Plasmid | SFFV-NPM1mA2-mScarlet | This paper | Lab ID: pJSG301 | |
| Construct/Plasmid | SFFV-NPM1mB1-mScarlet | This paper | Lab ID: pJSG306 | |
| Construct/Plasmid | SFFV-NPM1mA3-mScarlet | This paper | Lab ID: pJSG302 | |
| Construct/Plasmid | SFFV-NPM1mB2-mScarlet | This paper | Lab ID: pJSG303 | |
| Software | μManager | Edelstein et al., 2014 | Latest nightly build | https://micro-manager.org/ |
| Software | Pycromanager | Pinkard, H. et al., 2021 | https://github.com/micro-manager/pycro-manager/ | |
| Software | R | R Core Team, 2021 | v. 4.1.1 | https://www.r-project.org/ |
| Software | Prism | GraphPad | v. 8.3.0 | |
| Software | FIJI | Schindelin et al., 2012 | https://imagej.net/software/fiji/ | |
| Software | CellProfiler | Stirling, D. R. et al., 2021 | v.4.0.7 | https://cellprofiler.org/ |
| Oligonucleotide | 5′ETS RNA FISH probe | Integrated DNA Technologies | Cy5-CGGAGGCCCAACCTCTCCGACGACAGGTCGCCAGAGGACAGCGTGTCAGC | |
| Oligonucleotide | ITS1 RNA FISH probe | Integrated DNA Technologies | Cy5-CCTCGCCCTCCGGGCTCCGGGCTCCGTTAATGATC | |
| Oligonucleotide | ITS2 RNA FISH probe | Integrated DNA Technologies | Cy5-CTGCGAGGGAACCCCCAGCCGCGCA | |
| Oligonucleotide | ITS1 Northern probe | Integrated DNA Technologies | Biotin-CCTCGCCCTCCGGGCTCCGGGCTCCGTTAATGATC-Biotin | |
| Oligonucleotide | ITS2 Northern probe | Integrated DNA Technologies | Biotin-CTGCGAGGGAACCCCCAGCCGCGCA-Biotin | |
| Oligonucleotide | SKIV2L2 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-031902-02-0005 | |
| Oligonucleotide | UPF1 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-011763-00-0005 | |
| Oligonucleotide | DDX54 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-017128-01-0005 | |
| Oligonucleotide | eIF4A3 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-020762-00-0005 | |
| Oligonucleotide | NSA2 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-017043-01-0005 | |
| Oligonucleotide | MDN1 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-009786-00-0005 | |
| Oligonucleotide | RPF2 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-024715-01-0005 | |
| Oligonucleotide | GNL2 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-020392-01-0005 | |
| Oligonucleotide | PHF5A ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-014987-01-0005 | |
| Oligonucleotide | CNOT1 ON-TARGETplus siRNA SMARTPool | Horizon Discovery | Cat # L-015369-01-0005 | |
| Antibody | a-tubulin Monoclonal antibody (DM1A) | Invitrogen | Cat # 62204 | |
| Antibody | eIF4A3 polyclonal antibody (Rabbit) | Proteintech | Cat 3 17504-1AP | |
| Antibody | UPF1 (D15G6) Rabbit mAb | Cell Signaling Technology | Cat # 12040 | |
| Antibody | SKIV2L2 polyclonal antibody (Rabbit) | Novus Biologicals | Cat # NB100-1574 | |
| Antibody | DDX54 polyclonal antibody (Rabbit) | Proteintech | Cat # 26894-1AP | |
| Antibody | NOL1 Antibody | Novus Biologicals | Cat # NBP192192 | |
| Antibody | GNL2 Antibody | Novus Biologicals | Cat # NBP181649 | |
| Antibody | GLTSCR2 Polyclonal Antibody | Proteintech | Cat # 27353-1AP | |
| Antibody | BOP1 Polyclonal Antibody | Proteintech | Cat # 28366-1AP | |
| Antibody | RPS3 Antibody | Cell Signaling Technologies | Cat # 2579S | |
| Antibody | NPM1 Antibody | Invitrogen | Cat # 325200 | |
| Antibody | Goat anti-Mouse IgG (H+L) Cross-Absorbed Secondary Antibody, Alexa 647 | Invitrogen | Cat # A-21235 | |
| Antibody | Goat anti-Rabbit IgG (H+L) CrossAbsorbed Secondary Antibody, Alexa 647 | Invitrogen | Cat # A-21245 | |
| Antibody | Anti-mouse IgG, HRP-linked | Cell Signaling Technology | Cat # 7076S | |
| Antibody | Anti-Rabbit IgG (whole molecule)-Peroxidase antibody | Millipore | Cat # A0545-1ML | |
| Reagent | RFP-Trap Agarose | Chromotek | Cat # rta | |
| Chemical | Actinomycin D | Sigma | Cat # A1410-2MG | |
| Chemical | CX-5461 | SelleckChem | Cat # S2684 | |
| Chemical | Pladienlolide B | Tocris | Cat # 6070 | |
| Chemical | Sodium Arsenite | Millipore | Cat # 7784-46-5 | |
| Chemical | MG132 | SelleckChem | Cat # S2619 | |
| Chemical | SMG1i | Gift from Rosalind Franklin University of Medicine and Science and Cystic Fibrosis Foundation | ||
| Chemical | Hoechst 33342 | ThermoFisher | Cat # H3570 | |
| Chemical/Reagent | Lipofectamine LTX | ThermoFisher | Cat # 15338030 | |
| Chemical/Reagent | Lipofectamine 2000 | ThermoFisher | Cat # 11668027 | |
| Chemical/Reagent | Lipofectamine RNAiMAX | ThermoFisher | Cat # 13778075 | |
| Chemical/Reagent | SE Cell Line 4D-Nucleofector X Kit | Lonza | Cat # V4XC-1032 | |
| Chemical/Reagent | EnGen Spy Cas9 NLS | New England Biolabs | Cat # M0646T |
siRNA transfections
For screens and depooled validation experiments, siRNAs were reverse transfected at a final concentration of 5nM using Lipofectamine RNAiMAX reagent (Life Technologies). Briefly, siRNA:lipid mixes were pipetted into wells of a 384-well glass bottom dishes (Matriplate; Brooks). After a 15 min incubation, cells were seeded at 900 cells per well. Knockdown was allowed to proceed for 72 hr before imaging. For validation experiments (RNA FISH, IF, and single gene knockdowns), pooled guide RNAs were reverse transfected at a final concentration of 25 nM into 96-well glass-bottom imaging plates (Matriplate; Brooks), with cells seeded at a density of 8000 cells per well. For qPCR and westerns, cells were reverse transfected with pooled guide RNAs at a final concentration of 25 nM into 24-well tissue culture dishes (Corning) and cells were plated at 24,000 cells per well.
Drug treatments
For all drug treatments, cells were seeded at 50,000 cells per well into 96-well glass bottom imaging dishes (Matriplate; Brooks) 24 hr prior to experiments. For ATP depletion, cells were washed twice in DMEM without glucose (Gibco) and then incubated for 10 min with 10 mM sodium azide and 6mM 2-deoxyglucose diluted in DMEM without glucose supplemented with 10% tetracycline free FBS (Gemini). For sodium arsenite, cells were treated with 200 μm sodium arsenite diluted in culture media for 1 hr prior to imaging. For MG132, cells were treated with 10 μm MG132 diluted in culture media for 1 hr prior to imaging. For Pol I inhibitors, cells were treated with 0.04 μg/mL actinomycin D (Sigma) or 500 nM CX5461 (SelleckChem) diluted in culture media for 2 hr. For pladienolide B treatment, cells were treated with 10 nM PladB (Tocris, initially diluted in DMSO) diluted in culture media for 24 hr. For SMG1i treatment, cells were treated with 300 nM SMG1i (initially diluted in DMSO) diluted in culture media for 24 hr. All drug treatments were compared to cells treated with equal volumes of vehicle. For all imaging experiments, cells were transferred to heated and equilibrated microscope at least 30 min prior to imaging.
RNA fluorescent in situ hybridization (RNA FISH)
RNA FISH was performed in a 96-well plate format (see siRNA transfections). After knockdown or drug treatment, cells were fixed in 4% Paraformaldehyde in PBS at 37°C for 10 min. Cells were then permeabilized by incubation with ice-cold methanol at −20°C for 10 min. Cells were incubated with 1 M Tris pH 8 for approximately 10 min. 5' Cy5 labeled DNA probes (see Key Resources Table) were ordered from IDT and resuspended at 1 μg/mL in water. Stock probes were diluted 1:1000 in RNA FISH hybridization buffer preheated to 42°C (15% deionized formamide, 10% dextran sulfate, 2x SSC from Ambion, 0.02% BSA, 0.2 mg/mL Baker’s yeast tRNA from Ambion). Plate was placed in plastic bag with wet paper towels and incubated at 42°C for 1 hr. Cells were washed with 2x SSC three times at room temperature, followed by incubation with Hoechst 33342 DNA dye diluted at 1:1000 in 2x SSC for 10 min at room temperature. Cells were washed a final three times with 2x SSC and then imaged.
Immunofluorescence (IF)
Immunofluorescence was performed in 96-well plate format (see siRNA transfections). After knockdown or drug treatment, cells were fixed in 4% Paraformaldehyde in PBS at 37°C for 10 min. Cells were then permeabilized by incubation with ice-cold methanol at −20°C for 10 min. Fixed cells were blocked in 3% BSA in PBST (PBS from Gibco supplemented with 0.1% Tween-20) for at least 1 hr, followed by incubation overnight with primary antibodies diluted at 1:500 in antibody dilution buffer (3% BSA, PBST, 0.02% sodium azide). The following day, cells were washed three times with PBST followed by incubation for 1–2 hr at room temperature with appropriate secondary antibody conjugated to Alexa 647 (ThermoFisher) diluted at 1:1000 in antibody dilution buffer. Cells were then washed three times with PBST and incubated with Hoechst 33342 DNA dye (Invitrogen) diluted at 1:1000 for 10 min at room temperature. Cells were washed a final three times with PBST and then imaged.
NPM1 Immunoprecipitation for western blotting, northern blotting, and qPCR
15 cm dishes of NPM1-mScarlet expressing cells were seeded 24–48 hr prior to experiment such that cells were 70% confluent at time of harvest. Cells were washed once with ice cold PBS and then scraped into 1 mL ice cold lysis buffer (Pierce IP Lysis Buffer, ThermoFisher) supplemented with 0.5 mM TCEP and protease inhibitors (cOmplete Mini Tablets, Roche). Cells were sonicated at 30% power for 20 sec followed by ~2 min on ice, three times in total. Cells were then spun at 16,000 x g at 4°C for 10 min to remove cell debris. An aliquot of lysate was removed for input samples, and then the remainder was split into two parts and each bound to 25 μL RFP-Trap resin (slurry, which was first washed with 1 mL of lysis buffer). Samples were bound for 1 hr at 4°C while rotating. Resin was washed twice with lysis buffer and then 4 times with wash buffer (25 mM Tris pH 7.4, 150 mM NaCl, 1mM EDTA, 0.05% NP-40, 0.5 mM TCEP). Samples for western blot were then eluted directly in 50 μL sample buffer (2% SDS, 10 mM EDTA, 10% glycerol, 0.1% bromophenol blue, 50 mM Tris, pH 7.4, 100 mM DTT). Samples for qPCR were eluted directly into 100 μL TRIzol reagent (ThermoFisher). Sample preparation then continued as described below.
RT-qPCR
Cells were transfected in 24-well format, see siRNA transfection protocol above. After 72 hr of gene knockdown, cells were rinsed twice with ice-cold PBS (Gibco) and then scraped into 200 μL TRIzol Reagent (Invitrogen) and lysed by pipetting. Lysed cells were incubated for 5 min at room temperature. 40 μL chloroform was added and tubes were mixed by inversion followed by incubation for 2 minutes at room temperature. Samples were centrifuged for 15 min at 12,000 x g at 4°C. The aqueous phase was transferred to a new tube. RNA was extracted using Zymo RNA Clean and Concentrator kit according to manufacturer’s protocol. RNA was eluted in 15 μL RNase-free water (Ambion) and quantified by Nanodrop (ThermoFisher). cDNA was generated from 1 μg total RNA using iScript cDNA Synthesis Master Mix (Bio-Rad). cDNA was then diluted 1:20 for rRNA intermediates and 1:100 for mature rRNAs. RT-qPCR was performed using SYBR Green PCR Master Mix (Applied Biosystems) according to manufacturer’s protocol with a Bio-Rad CFX 96 Real Time thermal cycler. Reactions were run in technical triplicate and GAPDH was used as a housekeeping gene with the following primers:
GAPDH-F (5′-GTCTCCTCTGACTTCAACAGCG-3′)
GAPDH-R (5′-ACCACCCTGTTGCTGTAGCCAA-3′)
Primers used to amplify rRNA regions were as follows:
47S-F (5′-GAACGGTGGTGTGTCGTT-3′)
47S-R (5′-GCGTCTCGTCTCGTCTCACT-3′)
18S_5′-F (5′-GCCGCGCTCTACCTTACCTACCT-3′)
18S_5′-R (5′-CAGACATGCATGGCTTAATCTTTG-3′)
18S_3′-F (5′-AGTCGTAACAAGGTTTCCGTAGGT-3′)
18S_3′-R (5′-CCTCCGGGCTCCGTTAAT-3′)
5.8S_5′-F (5′-TACGACTCTTAGCGGTGGATCA-3′)
5.8S_5′-R (5′-TCACATTAATTCTCGCAGCTAGCT-3′)
5.8S_3′-F (5′-GAATTGCAGGACACATTGATCATC-3′)
5.8S_3′-R (5′-GGCAAGCGACGCTCAGA-3′)
18S-F (5′-CTGGATACCGCAGCTAGGAA-3′)
18S-R (5′-GAATTTCACCTCTAGCGGCG-3′)
5.8S-F (5′-ACTCGGCTCGTGCGTC -3′)
5.8S-R (5′-GCGACGCTCAGACAGG-3′)
28S-F (5′-CGGCGGGAGTAACTATGACT-3′)
28S-R (5′-GCTGTGGTTTCGCTGGATAG-3′)
Primers used for assessing gene depletions were as follows (designed using IDT PrimeTime):
MDN1 F: (5′-TTCGAGCACATTAAACAAGGC-3′)
MDN1 R: (5′-CCTCCTCTTCCTGATCTTTGC-3′)
NOG2 F: (5′-CCAATGAGAGCCACTTGT-3′)
NOG2 R: (5′-GATGGATTTGACCCTCACC-3′)
PHF5A F: (5′- ATTGTAAGGAGTCACCATCC-3′)
PHF5A R: (5′-GCGTTCATAGAAGAGGTCTGTC-3′)
CNOT1 F: (5′-CTGTCATACTGTTGCCACTGAT-3′)
CNOT1 R: (5′-CTCATACTCCCAACCTCTG-3′)
NSA2 F: (5′-TGAGACCCGAAAATTGAGAGC-3′)
NSA2 R: (5′-GGTAATCCAAACGGTATCCATAGC-3′)
RPF2 F: (5′-GTATGTTCTCACTTCACTGC-3′)
RPF2 R: (5′-ТСССАТСТСТТССААТТСААТСС-3′)
Western blotting
Cells were washed twice with ice-cold PBS and then scraped into RIPA buffer (ThermoFisher) supplemented with protease inhibitors (cOmplete Mini Tablets, Roche). Cells were lysed with a probe sonicator at 20% power in two 30-sec intervals on ice. Lysates were normalized by OD260 and denatured in sample buffer and boiled for 5 min at 95°C. Samples were run on a 4–20% Mini-PROTEAN TGX precast gel (Bio-Rad) and then transferred to nitrocellulose using a Bio-Rad TransBlot Turbo system. Membranes were blocked in 3% w/v BSA in TBST (50 mM Tris pH 8, 150 mM NaCl, 0.1% TWEEN-20) for 30 min and then incubated with primary antibodies overnight diluted at 1:1000 in antibody dilution buffer (3% BSA in TBST with 0.02% sodium azide). Membranes were washed three times in TBST and then incubated in 1:10,000 secondary antibody diluted in 3% BSA in TBST for 1–2 hr. Membranes were again washed three times in TBST and then incubated in SuperSignal West Pico Plus ECL substrate (ThermoFisher) and imaged on a Bio-Rad ChemiDOC MP Imaging system.
RNA electrophoresis and northern blotting
RNA was harvested and purified as in IPs or from total cells for qPCR as described above. Eluted RNA was diluted 1:1 in formamide RNA loading buffer (1mM EDTA pH 8, 60mM Tricine, 60mM Triethanolamine, 95% formamide, 0.03% bromophenol blue, 7% formaldehyde, 30μg/mL Ethidium bromide), denatured at 70°C for five minutes and then snap cooled on ice. 5μg RNA was electrophoresed in a 1% agarose gel made with 1x tricine-triethanolamine (TT) buffer (30mM tricine, 30mM triethanolamine) and 7% formaldehyde for 2–8 hours at 180 V with recirculation. The gel was subjected to mild alkaline treatment (10 min 75mM NaOH, 10 min 0.5 M Tris pH 7.4, 1.5 M NaCl, 10 min in 10x SSC) and then transferred by capillary transfer to BrightStar-Plus (Invitrogen) positively charged nylon membrane overnight in 10x SSC. RNA was UV crosslinked to the membrane and then chemiluminescent northern blotting using biotinylated probes was performed (Gregorova et al., 2026). Briefly, membranes were hybridized overnight at 50°C with 5′- and 3′-biotin-labeled DNA oligonucleotide probes targeting pre-rRNA regions (ITS1 and ITS2) in hybridization buffer (5× SSC, 5× Denhardťs solution, 0.5% SDS), washed sequentially, and probed with streptavidin-alkaline phosphatase (Invitrogen) and detected by chemiluminescence using Immun-Star AP substrate (Bio-Rad).
Sucrose gradient fractionation
NPM1-mutant cell lines were plated 24–48 hours prior to fractionation and harvested at 70% confluency. Nuclear fractions were obtained as previously described by Pestov et al. and separated on a 10–30% linear sucrose gradient by ultracentrifugation with a Sorvall TH-641 rotor for 3 hours at 36,000 rpm and fractionated using a BioComp gradient fractionator. Fractions were pooled as described in text. For protein isolation, 1% BSA was added as a carrier and then protein was precipitated using TCA. For RNA isolation, 200 μL of the fraction was combined with 600 μL Trizol and purified as described above.
Quantification of nucleolar RNA FISH and IF
Fixed-cell images were analyzed using custom pipelines developed in CellProfiler (Stirling, 2021) (v.4.0.7). Briefly, for nucleolar RNA FISH, nucleoli were segmented using the NPM1-tagged channel using adaptive Otsu thresholding. There is a higher nucleoplasmic signal for FISH samples, and therefore, three threshold classes were used and the bottom two were classified as background. The object diameter range was set to 10–300 pixels, and objects outside this range were discarded. Nucleoli that touch the border of the image were discarded. Identified nucleoli were shrunk by 1 pixel to eliminate impacts of edge effects on intensity measurements. Intensity of identified nucleoli objects were measured for both the unscaled NPM1-tagged channel and the stained channel. For IF, the same pipeline was used, but nucleoli were thresholded using two class thresholding. A custom Python script was used for post-processing of CellProfiler data to bin images by field of view and experimental condition. In addition, nucleoli that had an NPM1 intensity level of less than 0.01 were eliminated to omit fields of view with no cells, which resulted in inappropriate identification of background noise.
Quantification of western and northern blots
Western and Northern blot images were quantified using FIJI. Uncropped, unsaturated images (16-bit TIFF, acquired below pixel saturation) were used for all quantification. Bands of interest were selected using the rectangular selection tool, with a region large enough to encompass the full band including its edges, and identical box dimensions were applied across all lanes on a given blot. Mean gray value was measured and background was removed by subtracting the measurement of an equivalent-sized region immediately above or below each band. Background-subtracted band intensities were normalized to the corresponding loading control (for whole cell lysate western: tubulin, for IP-westerns: RFP, for IP-northerns: RFP from western), and normalized values were expressed relative to a control condition, which was set to 1.
Partition coefficient calculations
Partition coefficients were determined manually by quantifying relative nucleolar (Idense) and nucleoplasmic (Idilute) NPM1 intensities from pre-bleach (time point 0) images acquired by HiT-FRAP, as follows: Nucleolar signal was determined by measuring the average intensity of a 10 × 10 pixel box in the most intense region of nucleolar signal (5 × 5 pixels were used when nucleoli were small). Nucleoplasmic signal was determined by measuring the average intensity of a 10 × 10 pixel box that was manually chosen in the same cell as the measured nucleolus. Background was determined by averaging the average intensity across 5 randomly chosen 10 × 10 pixel locations. Background was subtracted, and then the ratio of nucleolar to nucleoplasmic signals were calculated to determine partition coefficient (K = Idense/Idilute, where K = partition coefficient).
RNA Helicase phylogenetic analysis
Full-length, reference protein sequences for indicated DEAD-box proteins were retrieved from NCBI and aligned using MUSCLE (Edgar, 2004). A maximum-likelihood tree was constructed using MEGA(Stecher et al., 2020) using default options and the JTT model.
Statistical analysis
Statistics for screen data are described above in “Dynamics screen phenotype analysis.”
For IF and FISH, means for each biological replicate (performed independently on a separate day) were determined as follows: each biological replicate was composed of three technical replicate wells. 200 nucleoli per well were analyzed, and combined to generate the n = 600 nucleoli per biological replicate. Mean for the biological replicate was determined from this pooled n = 600. p-values were calculated using a two-tailed unpaired t-test between the means of these biological replicates. Data distribution was assumed to be normal, but this was not formally tested. All statistical tests were performed in Prism 8.
Pearson correlation for t1/2 vs partition coefficients was calculated in R.
For NPM1 mutant partition coefficients and t1/2, 3 biological replicates were performed consisting of n individual nucleoli as indicated in figure legends. P-values were calculated using an unpaired t-test between means of biological replicates. Data was assumed to be normal, but this was not formally tested. All statistical tests were performed in Prism 8.
Use of AI
Portions of the manuscript text were revised with the assistance of Claude, Sonnet 4.6. All content was reviewed by authors.
Supplementary Material
Figure S5: Additional characterization of “Early” and “Other” phenotypic clusters. (A) Comparison between PolR1a knockdown (Early cluster) phenotype and treatment of cells with Pol I inhibitors (0.04 μg/mL ActD and 500 nM CX5461 for 2 hr). Images are scaled equally and colored with mpl-inferno LUT to show relative intensity differences of NPM1. Dotted line shows nuclear boundary. Scale bar is 10 μm. FRAP curves for NT/vehicle control vs. gene depletion/drug shown (n = 250 nucleoli, error bars are 95% CI). (B) Additional feature parameters for Pol1 inhibition as compared to Early cluster gene UTP15 depletion. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. Dotted line indicates control level. (C) Comparison between “Other” hit UPF2 and treatment with NMD inhibitor SMG1i (300 nM for 24 hr). Feature parameters for SMG1i treatment as compared to Other cluster gene UPF2 knockdown shown. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. (D) Comparison between “Other” representative hit PHF5A and treatment with splicing inhibitor PladB (10 nM for times indicated). Feature parameters for PladB inhibition (24 hr) as compared to Other cluster gene PHF5A knockdown shown. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. (E) Time course of PladB treatment (10 nM) using dual color cell line shown as merge of NPM1 (magenta) and FBL (green). Scale bar is 5 μm. While defects in dynamics were only detectable after 24 hours of treatment, nucleolar rounding occurred on shorter (0–4hr) time scales, which suggests an acute impact of splicing inhibition on nucleolar assembly. (F) qPCR to assess global rRNA precursor and mature rRNA levels for Other genes PHF5A and CNOT1. Error bars are SD, n = 3 independent replicates.
Figure S1: Schematic of pre-rRNA processing and NPM1 reporter cell line generation and characterization. (A) Schematic showing subset of rRNA processing steps in humans, with approximate localizations of probes used in FISH and northerns indicated. (B) Schematic for endogenous insertion of fluorescent protein tag at C-terminus of NPM1. Western blots for both mNeonGreen and mScarlet edited cell lines. Fusion protein and endogenous protein indicated. (C) Images and FRAP curves for mNeonGreen and mScarlet tagged lines. Scale bar is 10 μm. FRAP curves for n = 250 nucleoli, error bars are 95% CI. t1/2 and mobile fraction shown, mean ± SD. (D) Northern blot for cell lines used in this manuscript. ITS1 and ITS2 blots shown. Nonspecific signal from 28S and 18S indicated.
Figure S2: HiT-FRAP dynamics screen validation. (A) Maximum-likelihood phylogenetic tree for human DEAD-box helicases, with parenthetical orthologs and putative functions. Helicase pairs depleted in primary screen shown in orange, except for DDX19A/DDX19B. Scale bar represents mean number of nucleotide substitutions per site. (B) Volcano plot for mobile fraction for primary RNA helicase screen, highlighting helicase hits that resulted in increased (red) or decreased (blue) mobile fraction relative to non-targeting control cells (yellow; FDR < 0.05 and z-cutoff of ± 2.5 shown as dotted lines, see Methods). Non-significant gene targets shown in gray. x-axis plots robust z-score for mobile fraction (see Methods). (C) Depool validation of siRNA pool gene depletion strategy. t1/2 shown for NT (gray) and pool (blue) of indicated gene depletion. Individual guides shown in yellow. Values have been normalized to pool or single nontargeting guides, respectively. Error bars are 10–90 percentile. (D) Western blot for select hits to validate knockdown. (E) Volcano plot for t1/2 (left) and mobile fraction (right) for primary RNA helicase screen performed in NPM1-mScarlet reporter cell line, highlighting helicase hits that resulted in increased (red, “slower” and “more” for t1/2 and mobile fraction, respectively) or decreased (blue, “faster” and “less” for t1/2 and mobile fraction, respectively) t1/2 or mobile fraction relative to non-targeting control cells (yellow; FDR < 0.05 and z-cutoff of ± 2.5 shown as dotted lines, see Methods). Non-significant gene targets shown in gray. x-axis plots robust z-score for t1/2 (see Methods).
Figure S7: Further characterizing NPM1 mutants. (A) Western blot with NPM1 antibody in all NPM1 mutant cell lines used. Various species of NPM1 indicated. (B) Western blot with antibody that recognizes NPM1 for IP of NPM1 mutant constructs. Fusion protein (IP) and endogenous NPM1 bands indicated. Bottom, quantification of mutant to endogenous ratio, normalized to WT overexpression construct, across two replicates. Error bars are range, n = 2. (C) Western blot of NPM1 versus NPM1 knock out cell lines with antibody that recognizes NPM1. Below, representative images of NPM1 mutants in NPM1 knock out cells. Inverted LUT. Scale bar is 10 μm. (D) qPCR for rRNA precursors bound to NPM1 mutants. Primers indicated in schematic above. Fold change relative to IP of NPM1-WT, dotted line indicates 1 (no change). Error bars are SD, n = 3 independent replicates. (E) Sucrose gradient fractionation of nuclear pre-ribosomal complexes isolated from HeLa cells transduced with NPM1WT-mScarlet (blue curve), NPM1mA3-mScarlet (orange curve), and NPM1mB2-mScarlet (yellow curve). Cells in knock-out background shown as dotted line. (F) Western blot analysis of proteins from pooled sucrose gradient fractions, as shown in E. Ethidium bromide-stained gels of RNA from pooled fractions shown below. For knockout cell background, RFP* is the same blot as RFP but scaled to better show mB2 signal. Several panels are reproduced from Fig.6 for reference (from Fig. 6B: NPM1, BOP1, uS3, and ethidium bromide gel for NPM1 WT in WT endogenous background. From Fig. 6E: RFP for NPM1 WT, mA3, and mB2 in WT endogenous background.) (G) Characterizing trans interactions in pre-LSU phenotypic clusters. Left, schematics for proteins with IDRS lost and gained at transition from State F to States G/H and schematics of 28S showing uncompacted regions (unmodeled regions in structures) for each state. Right, schematics for proteins with IDRS lost and gained at transition from States G/H to State I and schematics of 28S showing uncompacted regions (unmodeled regions) for each state. PDB IDs used for this analysis: State F, 8FKY; State G, 8FKZ; State H, 8FL0; State I, 8FL2.
Figure S4: Phenotypic clustering and validation. (A) Dual color cell line (GC: NPM1-mScarlet, DFC: FBL-mScarlet, endogenously tagged) images for representative hits from phenotypic groups. Maximum intensity z-projection. Scale bar is 10 μm. (B) Immunofluorescence staining for GC marker SURF6 in representative hits from Early (ActD), Other (PHF5A), and LSU (RPF2) clusters. Scale bar is 10 μm. (C) qPCR showing fold change gene expression for select hits in each phenotypic cluster. NT = non-targeting control, Gene = siRNA against gene indicated. Internally normalized to GAPDH. Error bars are SD, n = 3 independent replicates. (D) Bleaching time course for disrupted LSU hits uL2 and eL39 showing bleach points target the nucleolar interior. Scale bar is 10 μm. (E) Depletion time course for representative hits from RNA Exosome (SKIV2L2), Other (PHF5A), and LSU (RPF2) phenotypic groups. Representative images of nucleolar phenotypes upon 24 hours and 48 hours post-siRNA transfection shown. Images scaled equally and colored with mpl-inferno LUT to show NPM1 intensity. Scale bar is 10 μm. (F) NPM1-mNeonGreen screen PCA shown colored by manually annotated function.
Figure S3: Phenotypic clustering features and validation. (A) PCA colored by six nucleolar features used in analysis. Viridis scale used, scale bar indicated. (B) Three biological replicates (in NPM1-mNeonGreen) cell line shown on same PCA. Select hits that fall in similar regions across 2 out of 3 replicates indicated. (C) PCA of replicated screens in NPM1-mScarlet cell line. Colored by manually annotated function. PC2 vs. PC1 and PC3 vs. PC1 shown. PCA loadings shown below. (D) Representative images of hit knockdowns in hTERT-RPE1 cells lentivirally expressing NPM1-mScarlet. Key morphological features shown below, normalized to NT. We note that baseline nucleolar size was smaller in RPE than HeLa cells, consistent with lower baseline ribosome biogenesis activity reported in non-transformed cells. We found that depletion of SKIV2L2 from the “RNA exosome” cluster shows a different phenotype than seen in HeLa cells, where we observe less size difference and a marked decrease in eccentricity, which may reflect a p53 or cell type specific response. Depletion of the “Other” cluster gene PHF5A results in a milder though qualitatively similar phenotype as seen in HeLa cells, with nucleolar rounding and an increase in NPM1 intensity. Depletion of “LSU”-associated hits in RPE cells very robustly replicated most of the nucleolar features we observed in HeLa, which suggest that these are likely generalizable responses to LSU disruption. Box and whisker shows median and 10–90 percentile. n = 500 nucleoli.
Figure S6: Further validation of phenotypic clusters. (A) Representative images for nucleolar rRNA FISH. Merge shows pseudocolor NPM1 (magenta) and rRNA (cyan). NPM1 and rRNA panels colored by Fire-LUT for each marker, respectively, to show intensity differences. Internal controls shown for each group of gene depletions. All images scaled equally with respect to internal control (i.e. NT on same plate, imaged together). Scale bar is 10 μm. (B) ITS1 and ITS2 northern blot for representative hits across phenotypic clusters. * = Nonspecific 28S and 18S. (C) qPCR to assess global rRNA precursor and mature rRNA levels for LSU1 (NSA2) and LSU2 (RPF2) genes. Schematic shows positions of primers used. Error bars are SD of three biological replicates. (D) rRNA FISH for representative LSU1 gene eL30 and LSU2 genes NOG2 and NOP53 as in Fig. 4A. For eL30 and NOP53, two biological replicates shown. (E) Representative immunofluorescence images shown for LSU hits. Merge shows pseudocolored markers NPM1 (magenta) and assembly factor (cyan). NPM1 and assembly factor panels colored by Fire-LUT for each marker, respectively, to show intensity differences. Internal controls (i.e. NT on same plate, imaged together) shown for each group of gene depletions. All images scaled equally with respect to internal control. Scale bar is 10 μm. (F) Nucleolar immunofluorescence of LSU intermediate markers for LSU1 gene eL30 and LSU2 gene NOG2 as in 5D. For eL30, two biological replicates shown.
Supplemental material summary
This article includes seven supplemental figures. Figure S1 outlines the pre-rRNA processing pathway and FISH/Northern probe positions used throughout the study and validates the two endogenously tagged NPM1 reporter cell lines. Figure S2 validates the primary RNA helicase screen, including helicase phylogeny and depooled siRNA and western blot confirmation of hits, and reproduces key results in an independent reporter cell line. Figure S3 validates the PCA-based phenotypic clustering strategy across biological replicates, both reporter cell lines, and an orthogonal, non-transformed cell type. Figure S4 provides further validation of the phenotypic clusters, including qPCR-confirmed knockdown efficiency, bleach spot placement within the nucleolar interior, phenotype onset timing, and orthogonal GC and DFC markers. Figure S5 shows that pharmacological inhibition of Pol I transcription, nonsense-mediated decay, and pre-mRNA splicing phenocopies representative gene knockdowns from the “Early” and “Other” clusters. Figure S6 extends rRNA FISH, Northern blot, qPCR, and immunofluorescence analyses to additional representative genes across the phenotypic clusters. Figure S7 further characterizes the panel of NPM1 IDR mutants, including their expression, localization, and pre-ribosome association in wild-type and NPM1-knockout backgrounds.
Acknowledgments
We thank Dyche Mullins and his lab for their generous support, and members of the Floor, Vale, and Sheu-Gruttadauria labs. SMG1i was provided by Robert Bridges, Ph.D. of the Rosalind Franklin University of Medicine and Science and Cystic Fibrosis Foundation Chemical Compound Program. JS-G is a Hanna H. Gray Fellow of the Howard Hughes Medical Institute. This work was supported by the National Institutes of Health R35GM149255 (to SNF). SNF was a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. RDV is supported by the Howard Hughes Medical Institute.
References
- A VB & S K. 2024. Aug. Eukaryotic Ribosome Assembly - PubMed. Annual review of biochemistry, 93. [DOI] [PubMed] [Google Scholar]
- AK G, T M, KV P, O R, JB F, S R, AB R, G S, AC M. & MM P. January/25/2019. Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1) - PubMed. Nucleic acids research, 47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ALBERTI S. & HYMAN AA 2021. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nature Reviews Molecular Cell Biology, 22, 196–213. [DOI] [PubMed] [Google Scholar]
- ALSHAREEDAH I, MOOSA MM, PHAM M, POTOYAN DA & BANERJEE PR 2021. Programmable viscoelasticity in protein-RNA condensates with disordered sticker-spacer polypeptides. Nature Communications, 12, 6620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- AV I, AV G, AA M. & GG K. 2018. May–Jun. The eS26 protein is involved in the formation of a nucleophosmin binding site on the human 40S ribosomal subunit - PubMed. Biochimica et biophysica acta. Proteins and proteomics, 1866. [DOI] [PubMed] [Google Scholar]
- BANANI SF, LEE HO, HYMAN AA & ROSEN MK 2017. Biomolecular condensates: organizers of cellular biochemistry. Nature Reviews Molecular Cell Biology, 18, 285–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BIEDKA S. 2018. Hierarchical recruitment of ribosomal proteins and assembly factors remodels nucleolar pre-60S ribosomes. Journal of Cell Biology, 217, 2503–2518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BOEYNAEMS S. 2019. Spontaneous driving forces give rise to protein-RNA condensates with coexisting phases and complex material properties. Proceedings of the National Academy of Sciences, 116, 7889–7898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BOHNSACK KE & BOHNSACK MT 2019. Uncovering the assembly pathway of human ribosomes and its emerging links to disease. The EMBO Journal, 38, e100278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BOHNSACK KE, YI S, VENUS S, JANKOWSKY E. & BOHNSACK MT 2023. Cellular functions of eukaryotic RNA helicases and their links to human diseases. Nature Reviews Molecular Cell Biology. [DOI] [PubMed] [Google Scholar]
- BOISVERT F-M, VAN KONINGSBRUGGEN S, NAVASCUéS J. & LAMOND AI 2007. The multifunctional nucleolus. Nature Reviews Molecular Cell Biology, 8, 574–585. [DOI] [PubMed] [Google Scholar]
- BRANGWYNNE CP, MITCHISON TJ & HYMAN AA 2011. Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes. Proceedings of the National Academy of Sciences, 108, 4334–4339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BROECK AV & KLINGE S. 2023. 0July–07. Principles of human pre-60S biogenesis. Science, 381. [DOI] [PubMed] [Google Scholar]
- BURGER F, DAUGERON M-C & LINDER P. 2000. Dbp10p, a putative RNA helicase from Saccharomyces cerevisiae, is required for ribosome biogenesis. Nucleic Acids Research, 28, 2315–2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CHENG HH, ROGGEVEEN JV, WANG H, STONE HA, SHI Z. & BRANGWYNNE CP 2025. Micropipette aspiration reveals differential RNA-dependent viscoelasticity of nucleolar subcompartments. Proceedings of the National Academy of Sciences, 122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CHLON TM 2021. Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell, 28, 1966–1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CHOUDHURY P, KRETSCHMER J, HACKERT P, BOHNSACK KE & BOHNSACK MT 2021. The DExD box ATPase DDX55 is recruited to domain IV of the 28S ribosomal RNA by its C-terminal region. RNA Biology, 18, 1124–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CORMAN A, SIROZH O, LAFARGA V. & FERNANDEZ-CAPETILLO O. 2023. Targeting the nucleolus as a therapeutic strategy in human disease. Trends in Biochemical Sciences, 48, 274–287. [DOI] [PubMed] [Google Scholar]
- D T, G T, A K, B VT, J P. & R P. February/06/2020. Modulation of RNA Condensation by the DEAD-Box Protein eIF4A - PubMed. Cell, 180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DARRIERE T. Upon heat stress processing of ribosomal RNA precursors into mature rRNAs is compromised after cleavage at primary P site in Arabidopsis thaliana. RNA Biology, 19, 719–734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DE PLANELL-SAGUER M, SCHROEDER DG, RODICIO MC, COX GA & MOURELATOS Z. 2009. Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Human Molecular Genetics, 18, 2115–2126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DEMBOWSKI JA, KUO B. & WOOLFORD JL 2013. Has1 regulates consecutive maturation and processing steps for assembly of 60S ribosomal subunits. Nucleic Acids Research, 41, 7889–7904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DIAS CS, ARAúJO NAM & TELO DA GAMA MM 2017. Dynamics of network fluids. Advances in Colloid and Interface Science, 247, 258–263. [DOI] [PubMed] [Google Scholar]
- DONATI G, MONTANARO L. & DERENZINI M. 2012. Ribosome Biogenesis and Control of Cell Proliferation: p53 Is Not Alone. Cancer Research, 72, 1602–1607. [DOI] [PubMed] [Google Scholar]
- DöRNER K, RUGGERI C, ZEMP I, KUTAY U, DöRNER K, RUGGERI C, ZEMP I. & KUTAY U. 2023. –02–0. Ribosome biogenesis factors—from names to functions. The EMBO Journal 2023 42:7, 42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DRYGIN D. 2011. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Research, 71, 1418–1430. [DOI] [PubMed] [Google Scholar]
- EDELSTEIN AD 2014. Advanced methods of microscope control using μManager software. Journal of Biological Methods, 1, e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EDGAR RC 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research, 32, 1792–1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ERDMANN PS 2021. In situ cryo-electron tomography reveals gradient organization of ribosome biogenesis in intact nucleoli. Nature Communications, 12, 5364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FARAG M. 2022. Condensates formed by prion-like low-complexity domains have small-world network structures and interfaces defined by expanded conformations. Nature Communications, 13, 7722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FARLEY-BARNES KI 2018. Diverse Regulators of Human Ribosome Biogenesis Discovered by Changes in Nucleolar Number. Cell Reports, 22, 1923–1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FERIC M. 2016. Coexisting Liquid Phases Underlie Nucleolar Subcompartments. Cell, 165, 1686–1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FERROLINO MC, MITREA DM, MICHAEL JR & KRIWACKI RW 2018. Compositional adaptability in NPM1-SURF6 scaffolding networks enabled by dynamic switching of phase separation mechanisms. Nature Communications, 9, 5064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOLKMANN AW, PUTNAM A, LEE CF & SEYDOUX G. 2021. Regulation of biomolecular condensates by interfacial protein clusters. Science, 373, 1218–1224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FROTTIN F. 2019. The nucleolus functions as a phase-separated protein quality control compartment. Science, 365, 342–347. [DOI] [PubMed] [Google Scholar]
- GAMALINDA M. 2014. A hierarchical model for assembly of eukaryotic 60S ribosomal subunit domains. Genes and Development, 28, 198–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GOLOMB L, VOLAREVIC S. & OREN M. 2014. p53 and ribosome biogenesis stress: The essentials. FEBS Letters, 588, 2571–2579. [DOI] [PubMed] [Google Scholar]
- GOPALSAMY A. 2012. Identification of pyrimidine derivatives as hSMG-1 inhibitors. Bioorganic and Medicinal Chemistry Letters, 22, 6636–6641. [DOI] [PubMed] [Google Scholar]
- GREGOROVA P, HEINONEN M-MK, LAARNE MM & SARIN LP 2026. Protocol for rapid tRNA enrichment and chemiluminescent northern blot detection of tRNA and tRNA-derived fragments. STAR Protocols, 7, 104357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HONDELE M. 2019. DEAD-box ATPases are global regulators of phase-separated organelles. Nature, 573, 144–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JALAL C, UHLMANN-SCHIFFLER H. & STAHL H. 2007. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Research, 35, 3590–3601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KANELLIS DC 2021. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Science Advances, 7, eabf7561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KL M. 2018. Employing CRISPR/Cas9 genome engineering to dissect the molecular requirements for mitosis - PubMed. Methods in cell biology, 144. [DOI] [PubMed] [Google Scholar]
- KLINGE S. & WOOLFORD JL 2019. Ribosome assembly coming into focus. Nature Reviews Molecular Cell Biology, 20, 116–131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KOLDE R. 2019. pheatmap: Pretty Heatmaps. [Google Scholar]
- KOTAKE Y. 2007. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nature Chemical Biology, 3, 570–575. [DOI] [PubMed] [Google Scholar]
- KRüGER T, ZENTGRAF H. & SCHEER U. 2007. Intranucleolar sites of ribosome biogenesis defined by the localization of early binding ribosomal proteins. Journal of Cell Biology, 177, 573–578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KWON I. 2014. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science, 345, 1139–1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAFONTAINE DLJ, RIBACK JA, BASCETIN R. & BRANGWYNNE CP 2021. The nucleolus as a multiphase liquid condensate. Nature Reviews Molecular Cell Biology, 22, 165–182. [DOI] [PubMed] [Google Scholar]
- LAPERUTA AJ 2023. Yeast ribosome biogenesis factors Puf6 and Nog2 and ribosomal proteins uL2 and eL43 act in concert to facilitate the release of nascent large ribosomal subunits from the nucleolus. Nucleic Acids Research, 51, 11277–11290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAPERUTA AJ, HEDAYATI S, MICIC J, FITZGERALD F, KIM D, OUALLINE G. & WOOLFORD JL 2023. Yeast ribosome biogenesis factors Puf6 and Nog2 and ribosomal proteins uL2 and eL43 act in concert to facilitate the release of nascent large ribosomal subunits from the nucleolus. Nucleic Acids Research, 51, 11277–11290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAPERUTA AJ, MICIC J. & WOOLFORD JL JR. 2022. Additional principles that govern the release of pre-ribosomes from the nucleolus into the nucleoplasm in yeast. Nucleic Acids Research. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LATONEN L, MOORE HM, BAI B, JääMAA S. & LAIHO M. 2011. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability. Oncogene, 30, 790–805. [DOI] [PubMed] [Google Scholar]
- LEMPIäINEN H. & SHORE D. 2009. Growth control and ribosome biogenesis. Current Opinion in Cell Biology, 21, 855–863. [DOI] [PubMed] [Google Scholar]
- LINSENMEIER M. 2022. Dynamic arrest and aging of biomolecular condensates are modulated by low-complexity domains, RNA and biochemical activity. Nature Communications, 13, 3030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LYON AS, PEEPLES WB & ROSEN MK 2021. A framework for understanding the functions of biomolecular condensates across scales. Nature Reviews Molecular Cell Biology, 22, 215–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MATSUMORI H, WATANABE K, TACHIWANA H, FUJITA T, ITO Y, TOKUNAGA M, SAKATA-SOGAWA K, OSAKADA H, HARAGUCHI T, AWAZU A, OCHIAI H, SAKATA Y, OCHIAI K, TOKI T, ITO E, GOLDBERG IG, TOKUNAGA K, NAKAO M. & SAITOH N. 2022. Mar 23. Ribosomal protein L5 facilitates rDNA-bundled condensate and nucleolar assembly. Life Science Alliance, 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MCKINLEY KL & CHEESEMAN IM 2017. Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects. Developmental Cell, 40, 405–420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MITREA DM 2016. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. eLife, 5, e13571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MITTAG T. & PAPPU RV 2022. A conceptual framework for understanding phase separation and addressing open questions and challenges. Molecular Cell, 82, 2201–2214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MITTERER V. & PERTSCHY B. RNA folding and functions of RNA helicases in ribosome biogenesis. RNA Biology, 19, 781–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOORE HM 2013. Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM. PLOS ONE, 8, e59096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NEUMüLLER RA 2013. Conserved Regulators of Nucleolar Size Revealed by Global Phenotypic Analyses. Science Signaling, 6, ra70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NICOLAS E. 2016. Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress. Nature Communications, 7, 11390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NUSSBACHER JK, TABET R, YEO GW & LAGIER-TOURENNE C. 2019. Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions. Neuron, 102, 294–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OGAWA LM 2021. Increased numbers of nucleoli in a genome-wide RNAi screen reveal proteins that link the cell cycle to RNA polymerase I transcription. Molecular Biology of the Cell, 32, 956–973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OHMAYER U, GAMALINDA M, SAUERT M, OSSOWSKI J, PöLL G, LINNEMANN J, HIERLMEIER T, PEREZ-FERNANDEZ J, KUMCUOGLU B, LEGER-SILVESTRE I, FAUBLADIER M, GRIESENBECK J, WOOLFORD J, TSCHOCHNER H. & MILKEREIT P. 2013. Jul 10. Studies on the Assembly Characteristics of Large Subunit Ribosomal Proteins in S. cerevisae. PLoS ONE, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- OKUWAKI M, SAITO S, HIRAWAKE-MOGI H. & NAGATA K. 2021. The interaction between nucleophosmin/NPM1 and the large ribosomal subunit precursors contribute to maintaining the nucleolar structure. Biochimica et Biophysica Acta - Molecular Cell Research, 1868, 118879. [DOI] [PubMed] [Google Scholar]
- OVERWIJN D. & HONDELE M. 2023. DEAD-box ATPases as regulators of biomolecular condensates and membrane-less organelles. Trends in Biochemical Sciences, 48, 244–258. [DOI] [PubMed] [Google Scholar]
- PERRY RP & KELLEY DE 1968. Persistent synthesis of 5S RNA when production of 28S and 18S ribosomal RNA is inhibited by low doses of actinomycin D. Journal of Cellular Physiology, 72, 235–245. [DOI] [PubMed] [Google Scholar]
- PERRY RP & KELLEY DE 1970. Inhibition of RNA synthesis by actinomycin D: Characteristic dose-response of different RNA species. Journal of Cellular Physiology, 76, 127–139. [DOI] [PubMed] [Google Scholar]
- PINKARD H. 2021. Pycro-Manager: open-source software for customized and reproducible microscope control. Nature Methods, 18, 226–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- QUINODOZ SA, JIANG L, ABU-ALFA AA, COMI TJ, ZHAO H, YU Q, WIESNER LW, BOTELLO JF, DONLIC A, SOEHALIM E, BHAT P, ZORBAS C, WACHEUL L, KOšMRLJ A, LAFONTAINE DLJ, KLINGE S, BRANGWYNNE CP, QUINODOZ SA, JIANG L, ABU-ALFA AA, COMI TJ, ZHAO H, YU Q, WIESNER LW, BOTELLO JF, DONLIC A, SOEHALIM E, BHAT P, ZORBAS C, WACHEUL L, KOšMRLJ A, LAFONTAINE DLJ, KLINGE S. & BRANGWYNNE CP 2025. –July–02. Mapping and engineering RNA-driven architecture of the multiphase nucleolus. Nature 2025 644:8076, 644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RIBACK JA 2020. Composition-dependent thermodynamics of intracellular phase separation. Nature, 581, 209–214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RIBACK JA 2023. Viscoelasticity and advective flow of RNA underlies nucleolar form and function. Molecular Cell, 83, 3095–3107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RODRíGUEZ-GALáN O, GARCíA-GóMEZ JJ, KRESSLER D. & DE LA CRUZ J. 2015. Immature large ribosomal subunits containing the 7S pre-rRNA can engage in translation in Saccharomyces cerevisiae. RNA Biology, 12, 838–846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SANDERS DW 2020. Competing Protein-RNA Interaction Networks Control Multiphase Intracellular Organization. Cell, 181, 306–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SARKAR A. 2017. Pre-ribosomes escaping from the nucleus are caught during translation by cytoplasmic quality control. Nature Structural and Molecular Biology, 24, 1107–1115. [DOI] [PubMed] [Google Scholar]
- SCHICHLER D, HAYASHI Y, FERNANDEZ L, CHUPANOVA M, HERNANDEZ-ARMENDARIZ A, NEUMANN B, CUYLEN-HAERING S, SCHICHLER D, HAYASHI Y, FERNANDEZ L, CHUPANOVA M, HERNANDEZ-ARMENDARIZ A, NEUMANN B. & CUYLEN-HAERING S. 2026–03–24. Ki-67 shapes the nucleolus by anchoring chromatin via its amphiphilic properties. The EMBO Journal 2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHAN L, XU G, YAO R-W, LUAN P-F, HUANG Y, ZHANG P-H, PAN Y-H, ZHANG L, GAO X, LI Y, CAO S-M, GAO S-X, YANG Z-H, LI S, YANG L-Z, WANG Y, WONG CCL, YU L, LI J, YANG L. & CHEN L-L 2023. Nucleolar URB1 ensures 3ʹ ETS rRNA removal to prevent exosome surveillance. Nature, 615, 526–534. [DOI] [PubMed] [Google Scholar]
- SHIN Y. & BRANGWYNNE CP 2017. Liquid phase condensation in cell physiology and disease. Science, 357. [DOI] [PubMed] [Google Scholar]
- SINGH S, VANDEN BROECK A, MILLER L, CHAKER-MARGOT M. & KLINGE S. 2021. Nucleolar maturation of the human small subunit processome. Science, 373, eabj5338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SLOWIKOWSKI K. 2023. ggrepel: Automatically Position Non-Overlapping Text Labels with 'ggplot2'. [Google Scholar]
- STECHER G, TAMURA K. & KUMAR S. 2020. Molecular Evolutionary Genetics Analysis (MEGA) for macOS. Molecular Biology and Evolution, 37, 1237–1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STENSTRöM L. 2020. Mapping the nucleolar proteome reveals a spatiotemporal organization related to intrinsic protein disorder. Molecular Systems Biology, 16, e9469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STIRLING DR 2021. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics, 22, 433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SUZUKI H, SHIBAGAKI Y, HATTORI S. & MATSUOKA M. 2018. The proline-arginine repeat protein linked to C9-ALS/FTD causes neuronal toxicity by inhibiting the DEAD-box RNA helicase-mediated ribosome biogenesis. Cell Death and Disease, 9, 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SZAFLARSKI W. 2022. Early rRNA processing is a stress-dependent regulatory event whose inhibition maintains nucleolar integrity. Nucleic Acids Research, 50, 1033–1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SZKLARCZYK D. 2023. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51, D638–D646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TANG Y, HORIKOSHI M. & LI W. 2016. ggfortify: Unified Interface to Visualize Statistical Result of Popular R Packages. The R Journal, 8, 474–485. [Google Scholar]
- TAYLOR NO, WEI M-T, STONE HA & BRANGWYNNE CP 2019. Quantifying Dynamics in Phase-Separated Condensates Using Fluorescence Recovery after Photobleaching. Biophysical Journal, 117, 1285–1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- V S, P P, C DV& DLJ L. 2018. Oct. Use of the iNo score to discriminate normal from altered nucleolar morphology, with applications in basic cell biology and potential in human disease diagnostics - PubMed. Nature protocols, 13. [DOI] [PubMed] [Google Scholar]
- VAN DER WALT S. 2014. scikit-image: image processing in Python. PeerJ, 2, e453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WANG J. 2018. A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins. Cell, 174, 688–699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WANG Z, LOU J. & ZHANG H. 2022. Essence determines phenomenon: Assaying the material properties of biological condensates. Journal of Biological Chemistry, 298, 101782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WICKHAM H. ggplot2: Elegant Graphics for Data Analysis, Springer-Verlag New York. [Google Scholar]
- YAO R-W 2019. Nascent Pre-rRNA Sorting via Phase Separation Drives the Assembly of Dense Fibrillar Components in the Human Nucleolus. Molecular Cell, 76, 767–783. [DOI] [PubMed] [Google Scholar]
- ZHANG Y. 2023. Interface resistance of biomolecular condensates. eLife, 12. [Google Scholar]
- ZHU L. 2019. Controlling the material properties and rRNA processing function of the nucleolus using light. Proceedings of the National Academy of Sciences, 116, 17330–17335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ZORBAS C, SOENMEZ A, LéGER J, DE VLEESCHOUWER C. & LAFONTAINE DLJ 2024. Detecting material state changes in the nucleolus by label-free digital holographic microscopy. EMBO Reports, 25, 2786–2811. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S5: Additional characterization of “Early” and “Other” phenotypic clusters. (A) Comparison between PolR1a knockdown (Early cluster) phenotype and treatment of cells with Pol I inhibitors (0.04 μg/mL ActD and 500 nM CX5461 for 2 hr). Images are scaled equally and colored with mpl-inferno LUT to show relative intensity differences of NPM1. Dotted line shows nuclear boundary. Scale bar is 10 μm. FRAP curves for NT/vehicle control vs. gene depletion/drug shown (n = 250 nucleoli, error bars are 95% CI). (B) Additional feature parameters for Pol1 inhibition as compared to Early cluster gene UTP15 depletion. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. Dotted line indicates control level. (C) Comparison between “Other” hit UPF2 and treatment with NMD inhibitor SMG1i (300 nM for 24 hr). Feature parameters for SMG1i treatment as compared to Other cluster gene UPF2 knockdown shown. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. (D) Comparison between “Other” representative hit PHF5A and treatment with splicing inhibitor PladB (10 nM for times indicated). Feature parameters for PladB inhibition (24 hr) as compared to Other cluster gene PHF5A knockdown shown. Points are individual nucleoli, n = 500. Error bars are mean ± SD. Normalized to appropriate control to account for imaging differences. (E) Time course of PladB treatment (10 nM) using dual color cell line shown as merge of NPM1 (magenta) and FBL (green). Scale bar is 5 μm. While defects in dynamics were only detectable after 24 hours of treatment, nucleolar rounding occurred on shorter (0–4hr) time scales, which suggests an acute impact of splicing inhibition on nucleolar assembly. (F) qPCR to assess global rRNA precursor and mature rRNA levels for Other genes PHF5A and CNOT1. Error bars are SD, n = 3 independent replicates.
Figure S1: Schematic of pre-rRNA processing and NPM1 reporter cell line generation and characterization. (A) Schematic showing subset of rRNA processing steps in humans, with approximate localizations of probes used in FISH and northerns indicated. (B) Schematic for endogenous insertion of fluorescent protein tag at C-terminus of NPM1. Western blots for both mNeonGreen and mScarlet edited cell lines. Fusion protein and endogenous protein indicated. (C) Images and FRAP curves for mNeonGreen and mScarlet tagged lines. Scale bar is 10 μm. FRAP curves for n = 250 nucleoli, error bars are 95% CI. t1/2 and mobile fraction shown, mean ± SD. (D) Northern blot for cell lines used in this manuscript. ITS1 and ITS2 blots shown. Nonspecific signal from 28S and 18S indicated.
Figure S2: HiT-FRAP dynamics screen validation. (A) Maximum-likelihood phylogenetic tree for human DEAD-box helicases, with parenthetical orthologs and putative functions. Helicase pairs depleted in primary screen shown in orange, except for DDX19A/DDX19B. Scale bar represents mean number of nucleotide substitutions per site. (B) Volcano plot for mobile fraction for primary RNA helicase screen, highlighting helicase hits that resulted in increased (red) or decreased (blue) mobile fraction relative to non-targeting control cells (yellow; FDR < 0.05 and z-cutoff of ± 2.5 shown as dotted lines, see Methods). Non-significant gene targets shown in gray. x-axis plots robust z-score for mobile fraction (see Methods). (C) Depool validation of siRNA pool gene depletion strategy. t1/2 shown for NT (gray) and pool (blue) of indicated gene depletion. Individual guides shown in yellow. Values have been normalized to pool or single nontargeting guides, respectively. Error bars are 10–90 percentile. (D) Western blot for select hits to validate knockdown. (E) Volcano plot for t1/2 (left) and mobile fraction (right) for primary RNA helicase screen performed in NPM1-mScarlet reporter cell line, highlighting helicase hits that resulted in increased (red, “slower” and “more” for t1/2 and mobile fraction, respectively) or decreased (blue, “faster” and “less” for t1/2 and mobile fraction, respectively) t1/2 or mobile fraction relative to non-targeting control cells (yellow; FDR < 0.05 and z-cutoff of ± 2.5 shown as dotted lines, see Methods). Non-significant gene targets shown in gray. x-axis plots robust z-score for t1/2 (see Methods).
Figure S7: Further characterizing NPM1 mutants. (A) Western blot with NPM1 antibody in all NPM1 mutant cell lines used. Various species of NPM1 indicated. (B) Western blot with antibody that recognizes NPM1 for IP of NPM1 mutant constructs. Fusion protein (IP) and endogenous NPM1 bands indicated. Bottom, quantification of mutant to endogenous ratio, normalized to WT overexpression construct, across two replicates. Error bars are range, n = 2. (C) Western blot of NPM1 versus NPM1 knock out cell lines with antibody that recognizes NPM1. Below, representative images of NPM1 mutants in NPM1 knock out cells. Inverted LUT. Scale bar is 10 μm. (D) qPCR for rRNA precursors bound to NPM1 mutants. Primers indicated in schematic above. Fold change relative to IP of NPM1-WT, dotted line indicates 1 (no change). Error bars are SD, n = 3 independent replicates. (E) Sucrose gradient fractionation of nuclear pre-ribosomal complexes isolated from HeLa cells transduced with NPM1WT-mScarlet (blue curve), NPM1mA3-mScarlet (orange curve), and NPM1mB2-mScarlet (yellow curve). Cells in knock-out background shown as dotted line. (F) Western blot analysis of proteins from pooled sucrose gradient fractions, as shown in E. Ethidium bromide-stained gels of RNA from pooled fractions shown below. For knockout cell background, RFP* is the same blot as RFP but scaled to better show mB2 signal. Several panels are reproduced from Fig.6 for reference (from Fig. 6B: NPM1, BOP1, uS3, and ethidium bromide gel for NPM1 WT in WT endogenous background. From Fig. 6E: RFP for NPM1 WT, mA3, and mB2 in WT endogenous background.) (G) Characterizing trans interactions in pre-LSU phenotypic clusters. Left, schematics for proteins with IDRS lost and gained at transition from State F to States G/H and schematics of 28S showing uncompacted regions (unmodeled regions in structures) for each state. Right, schematics for proteins with IDRS lost and gained at transition from States G/H to State I and schematics of 28S showing uncompacted regions (unmodeled regions) for each state. PDB IDs used for this analysis: State F, 8FKY; State G, 8FKZ; State H, 8FL0; State I, 8FL2.
Figure S4: Phenotypic clustering and validation. (A) Dual color cell line (GC: NPM1-mScarlet, DFC: FBL-mScarlet, endogenously tagged) images for representative hits from phenotypic groups. Maximum intensity z-projection. Scale bar is 10 μm. (B) Immunofluorescence staining for GC marker SURF6 in representative hits from Early (ActD), Other (PHF5A), and LSU (RPF2) clusters. Scale bar is 10 μm. (C) qPCR showing fold change gene expression for select hits in each phenotypic cluster. NT = non-targeting control, Gene = siRNA against gene indicated. Internally normalized to GAPDH. Error bars are SD, n = 3 independent replicates. (D) Bleaching time course for disrupted LSU hits uL2 and eL39 showing bleach points target the nucleolar interior. Scale bar is 10 μm. (E) Depletion time course for representative hits from RNA Exosome (SKIV2L2), Other (PHF5A), and LSU (RPF2) phenotypic groups. Representative images of nucleolar phenotypes upon 24 hours and 48 hours post-siRNA transfection shown. Images scaled equally and colored with mpl-inferno LUT to show NPM1 intensity. Scale bar is 10 μm. (F) NPM1-mNeonGreen screen PCA shown colored by manually annotated function.
Figure S3: Phenotypic clustering features and validation. (A) PCA colored by six nucleolar features used in analysis. Viridis scale used, scale bar indicated. (B) Three biological replicates (in NPM1-mNeonGreen) cell line shown on same PCA. Select hits that fall in similar regions across 2 out of 3 replicates indicated. (C) PCA of replicated screens in NPM1-mScarlet cell line. Colored by manually annotated function. PC2 vs. PC1 and PC3 vs. PC1 shown. PCA loadings shown below. (D) Representative images of hit knockdowns in hTERT-RPE1 cells lentivirally expressing NPM1-mScarlet. Key morphological features shown below, normalized to NT. We note that baseline nucleolar size was smaller in RPE than HeLa cells, consistent with lower baseline ribosome biogenesis activity reported in non-transformed cells. We found that depletion of SKIV2L2 from the “RNA exosome” cluster shows a different phenotype than seen in HeLa cells, where we observe less size difference and a marked decrease in eccentricity, which may reflect a p53 or cell type specific response. Depletion of the “Other” cluster gene PHF5A results in a milder though qualitatively similar phenotype as seen in HeLa cells, with nucleolar rounding and an increase in NPM1 intensity. Depletion of “LSU”-associated hits in RPE cells very robustly replicated most of the nucleolar features we observed in HeLa, which suggest that these are likely generalizable responses to LSU disruption. Box and whisker shows median and 10–90 percentile. n = 500 nucleoli.
Figure S6: Further validation of phenotypic clusters. (A) Representative images for nucleolar rRNA FISH. Merge shows pseudocolor NPM1 (magenta) and rRNA (cyan). NPM1 and rRNA panels colored by Fire-LUT for each marker, respectively, to show intensity differences. Internal controls shown for each group of gene depletions. All images scaled equally with respect to internal control (i.e. NT on same plate, imaged together). Scale bar is 10 μm. (B) ITS1 and ITS2 northern blot for representative hits across phenotypic clusters. * = Nonspecific 28S and 18S. (C) qPCR to assess global rRNA precursor and mature rRNA levels for LSU1 (NSA2) and LSU2 (RPF2) genes. Schematic shows positions of primers used. Error bars are SD of three biological replicates. (D) rRNA FISH for representative LSU1 gene eL30 and LSU2 genes NOG2 and NOP53 as in Fig. 4A. For eL30 and NOP53, two biological replicates shown. (E) Representative immunofluorescence images shown for LSU hits. Merge shows pseudocolored markers NPM1 (magenta) and assembly factor (cyan). NPM1 and assembly factor panels colored by Fire-LUT for each marker, respectively, to show intensity differences. Internal controls (i.e. NT on same plate, imaged together) shown for each group of gene depletions. All images scaled equally with respect to internal control. Scale bar is 10 μm. (F) Nucleolar immunofluorescence of LSU intermediate markers for LSU1 gene eL30 and LSU2 gene NOG2 as in 5D. For eL30, two biological replicates shown.
